# EDGAR Filing Document

**Accession Number:** 0001830033
**File Stem:** 0001193125-25-269651
**Filing Date:** 2025-11
**Character Count:** 194425
**Document Hash:** 82d1ebe4e120d3066bf8ad8bf82bd31e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-269651.hdr.sgml**: 20251106

**ACCESSION NUMBER**: 0001193125-25-269651

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 86

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251106

**DATE AS OF CHANGE**: 20251106

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PureCycle Technologies, Inc.
- **CENTRAL INDEX KEY:** 0001830033
- **STANDARD INDUSTRIAL CLASSIFICATION:** PLASTICS, MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS [2821]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** X1
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40234
- **FILM NUMBER:** 251458742

**BUSINESS ADDRESS:**
- **STREET 1:** 20 NORTH ORANGE AVE
- **STREET 2:** SUITE 106
- **CITY:** ORLANDO
- **STATE:** FL
- **ZIP:** 32801
- **BUSINESS PHONE:** 877-648-3565

**MAIL ADDRESS:**
- **STREET 1:** 20 NORTH ORANGE AVE
- **STREET 2:** SUITE 106
- **CITY:** ORLANDO
- **STATE:** FL
- **ZIP:** 32801

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Roth CH Acquisition I Co. Parent Corp.
- **DATE OF NAME CHANGE:** 20201026

?xml version='1.0' encoding='ASCII'? 10-Q

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM** 10-Q

------

**(Mark One)**

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** 

**For the quarterly period ended** **September 30,** 2025

**or**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from ________to ________**

**Commission File Number:** 001-40234

------

![img15858195_0.jpg](img15858195_0.jpg)

**PureCycle** **Technologies, Inc.**

(Exact name of registrant as specified in its charter)

------

Delaware 86-2293091 <br> (State or other jurisdiction of incorporation or organization) (I.R.S. EmployerIdentification No.)

20 North Orange Avenue**,** Suite 106

Orlando**,** Florida 32801

**(**877**)** 648-3565

(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)

------

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **<u>Title of each class</u>** | **<u>Trading Symbols</u>** | **<u>Name of each exchange on which registered</u>** |
| Common Stock, par value $0.001 par value per share | PCT | The Nasdaq Stock Market LLC |
| Warrants, each exercisable for one share of Common Stock, $0.001 par value per share, at an exercise price of $11.50 per share | PCTTW | The Nasdaq Stock Market LLC |
| Units, each consisting of one share of Common Stock, $0.001 par value per share, and three quarters of one warrant | PCTTU | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
|  |  | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of November 4, 2025, there were approximately 180,198,340 shares of the registrant's Common Stock, par value $0.001 per share, outstanding.

------

**PureCycle Technologies, Inc.**

**QUARTERLY REPORT ON FORM 10-Q**

**TABLE OF CONTENTS**

---

| | |
|:---|:---|
|  | Page |
| **PART I - FINANCIAL INFORMATION** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Item 1. Financial Statements |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Condensed Consolidated Balance Sheets as of September 30, 2025 (Unaudited) and December 31, 2024](#condensed_consolidated_balance_sheets) | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Condensed Consolidated Statements of Comprehensive Loss for the Three and Nine Months ended September 30, 2025 and 2024](#statements_comprehensive_income)[(Unaudited)](#statements_stockholders_equity) | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Condensed Consolidated Statements of Mezzanine Equity and Stockholders' Equity for the Three and Nine Months ended September 30, 2025 and 2024 (Unaudited)](#statements_stockholders_equity) | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Condensed Consolidated Statements of Cash Flows for the Nine Months ended September 30, 2025 and 2024](#consolidated_statements_cash_flows)(Unaudited) | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Notes to the Condensed Consolidated Financial Statements](#notes_to_the_interim_condensed) (Unaudited) | 8 |
| &nbsp;&nbsp;&nbsp;&nbsp;[Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](#item2_management_discussion_analysis) | 38 |
| &nbsp;&nbsp;&nbsp;&nbsp;[Item 3. Quantitative and Qualitative Disclosures About Market Risk](#item3_quantitative_and_qualitative) | 50 |
| &nbsp;&nbsp;&nbsp;&nbsp;[Item 4. Controls and Procedures](#item4_controls_and_procedures) | 50 |
| **PART II - OTHER INFORMATION** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;[Item 1. Legal Proceedings](#item1_legal_proceedings) | 51 |
| &nbsp;&nbsp;&nbsp;&nbsp;[Item 1A. Risk Factors](#item1a_risk_factors) | 51 |
| &nbsp;&nbsp;&nbsp;&nbsp;[Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](#item2_unregistered_sales_of_equity) | 51 |
| &nbsp;&nbsp;&nbsp;&nbsp;[Item 5. Other Information](#item5_other_information) | 52 |
| &nbsp;&nbsp;&nbsp;&nbsp;[Item 6. Exhibits](#item6_exhibits) | 53 |
| [SIGNATURES](#signatures) | 55 |

---

------

**PART I - FINANCIAL INFORMATION**

**Item 1. Financial Statements**

**PureCycle Technologies, Inc.**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
| ***(in thousands, except per share data)*** | **September 30, 2025** | **December 31, 2024** |
| **ASSETS** |  |  |
| **CURRENT ASSETS** |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $234359 | $15683 |
| &nbsp;&nbsp;&nbsp;Restricted cash – current | 3582 | 16656 |
| &nbsp;&nbsp;&nbsp;Accounts receivable, net | 1595 |  |
| &nbsp;&nbsp;&nbsp;Inventory | 10725 | 8087 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 15185 | 13473 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 265446 | 53899 |
| Restricted cash – noncurrent | 9312 | 9172 |
| Operating lease right-of-use assets | 54957 | 56833 |
| Property, plant and equipment, net | 655974 | 674079 |
| Prepaid expenses and other noncurrent assets | 3434 | 4402 |
| **TOTAL ASSETS** | $989123 | $798385 |
| **LIABILITIES, MEZZANINE EQUITY, AND STOCKHOLDERS' EQUITY** | **LIABILITIES, MEZZANINE EQUITY, AND STOCKHOLDERS' EQUITY** | **LIABILITIES, MEZZANINE EQUITY, AND STOCKHOLDERS' EQUITY** |
| **CURRENT LIABILITIES** |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable | $4408 | $6596 |
| &nbsp;&nbsp;&nbsp;Accrued expenses and other current liabilities | 23494 | 43259 |
| &nbsp;&nbsp;&nbsp;Accrued interest | 6434 | 7626 |
| &nbsp;&nbsp;&nbsp;Current portion of warrant liability | 60235 | 10109 |
| &nbsp;&nbsp;&nbsp;Current portion of long-term debt | 10289 | 12932 |
| &nbsp;&nbsp;&nbsp;Current portion of related party bonds payable | 13540 | 10355 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 118400 | 90877 |
| **NONCURRENT LIABILITIES** |  |  |
| &nbsp;&nbsp;&nbsp;Deferred revenue | 5000 | 5000 |
| &nbsp;&nbsp;&nbsp;Long-term debt, less current portion | 276853 | 256886 |
| &nbsp;&nbsp;&nbsp;Related party bonds payable, less current portion | 78405 | 66471 |
| &nbsp;&nbsp;&nbsp;Warrant liability, less current portion | 62258 | 120090 |
| &nbsp;&nbsp;&nbsp;Operating lease right-of-use liabilities | 53055 | 54665 |
| &nbsp;&nbsp;&nbsp;Series A Preferred Stock liability | 26259 | 18433 |
| &nbsp;&nbsp;&nbsp;Other noncurrent liabilities | 1370 | 5514 |
| **TOTAL LIABILITIES** | 621600 | 617936 |
| COMMITMENTS AND CONTINGENCIES (NOTE 10) |  |  |
| **MEZZANINE EQUITY** |  |  |
| &nbsp;&nbsp;&nbsp;Series B Convertible Perpetual Preferred Stock - $0.001 par value, 300 and no shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively | 299304 |  |
| **STOCKHOLDERS' EQUITY** |  |  |
| &nbsp;&nbsp;&nbsp;Common Stock - $0.001 par value, 450,000 shares authorized; 180,191 and 173,566 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively | 180 | 174 |
| &nbsp;&nbsp;&nbsp;Additional paid-in capital | 865444 | 813573 |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive (loss)/income | (251) | 78 |
| &nbsp;&nbsp;&nbsp;Accumulated deficit | (797154) | (633376) |
| **TOTAL STOCKHOLDERS' EQUITY** | 68219 | 180449 |
| **TOTAL LIABILITIES, MEZZANINE EQUITY, AND STOCKHOLDERS' EQUITY** | $989123 | $798385 |

---

*The accompanying notes are an integral part of these condensed consolidated financial statements.*

------

**PureCycle Technologies, Inc.**

**CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS**

**(Unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| ***(in thousands, except per share data)*** | **2025** | **2024** | **2025** | **2024** |
| **Revenues** | $2430 | $— | $5660 | $— |
| **Operating expenses** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Cost of operations | 29570 | 16965 | 82843 | 60379 |
| &nbsp;&nbsp;&nbsp;Research and development | 1443 | 1544 | 4381 | 4940 |
| &nbsp;&nbsp;&nbsp;Selling, general and administrative | 10350 | 12789 | 40688 | 44883 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating costs and expenses | 41363 | 31298 | 127912 | 110202 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating loss | (38933) | (31298) | (122252) | (110202) |
| **Other expense/(income):** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest expense | 16235 | 14567 | 48939 | 41676 |
| &nbsp;&nbsp;&nbsp;Interest income | (2850) | (414) | (3850) | (4530) |
| &nbsp;&nbsp;&nbsp;Change in fair value of warrants | (23745) | 44899 | 1881 | 54532 |
| &nbsp;&nbsp;&nbsp;Loss on extinguishment of debt |  |  |  | 21214 |
| &nbsp;&nbsp;&nbsp;Other (income)/expense | (203) | 289 | (5444) | 1364 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total other (income)/expense | (10563) | 59341 | 41526 | 114256 |
| Net loss | $(28370) | $(90639) | $(163778) | $(224458) |
| **Loss per share** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic | $(0.19) | $(0.54) | $(0.95) | $(1.36) |
| &nbsp;&nbsp;&nbsp;Diluted | $(0.31) | $(0.54) | $(1.07) | $(1.36) |
| **Weighted average common shares** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic | 180069 | 166513 | 179024 | 165224 |
| &nbsp;&nbsp;&nbsp;Diluted | 184551 | 166513 | 180518 | 165224 |
| **Other comprehensive (loss)/income** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Cumulative translation adjustment | $(20) | $(66) | $(329) | $(41) |
| &nbsp;&nbsp;&nbsp;Unrealized gain on debt securities available for sale |  |  |  | 18 |
| Total comprehensive loss | $(28390) | $(90705) | $(164107) | $(224481) |

---

*The accompanying notes are an integral part of these condensed consolidated financial statements.*

------

**PureCycle Technologies, Inc.**

**CONDENSED CONSOLIDATED STATEMENTS OF MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY**

**(Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **For the Three and Nine Months Ended September 30, 2025** | **For the Three and Nine Months Ended September 30, 2025** | **For the Three and Nine Months Ended September 30, 2025** | **For the Three and Nine Months Ended September 30, 2025** | **For the Three and Nine Months Ended September 30, 2025** | **For the Three and Nine Months Ended September 30, 2025** | **For the Three and Nine Months Ended September 30, 2025** | **For the Three and Nine Months Ended September 30, 2025** |
|  | **Mezzanine Equity** | **Mezzanine Equity** | **Stockholders' Equity** | **Stockholders' Equity** | **Stockholders' Equity** | **Stockholders' Equity** | **Stockholders' Equity** | **Stockholders' Equity** |
|  | **Series B Convertible Perpetual Preferred Stock** | **Series B Convertible Perpetual Preferred Stock** | **Common Stock** | **Common Stock** | **Additional Paid-in Capital** | **Accumulated Other Comprehensive Income/(Loss)** | **Accumulated Deficit** | **Total Stockholders' Equity** |
| ***(in thousands)*** | **Shares** | **Amount** | **Shares** | **Amount** |  |  |  |  |
| **Balance, December 31, 2024** |  | $— | 173566 | $174 | $813573 | $78 | $(633376) | $180449 |
| &nbsp;&nbsp;&nbsp;Issuance of Common Stock |  |  | 4091 | 4 | 33148 |  |  | 33152 |
| &nbsp;&nbsp;&nbsp;Warrants exercised |  |  | 1511 | 1 | 14216 |  |  | 14217 |
| &nbsp;&nbsp;&nbsp;Share repurchase |  |  | (187) |  | (1697) |  |  | (1697) |
| &nbsp;&nbsp;&nbsp;Equity-based compensation |  |  | 554 | 1 | 3353 |  |  | 3354 |
| &nbsp;&nbsp;&nbsp;Cumulative translation adjustment |  |  |  |  |  | (94) |  | (94) |
| &nbsp;&nbsp;&nbsp;Net income |  |  |  |  |  |  | 8832 | 8832 |
| **Balance, March 31, 2025** | **—** | **—** | **179535** | **180** | **862593** | **(16)** | **(624544)** | **238213** |
| &nbsp;&nbsp;&nbsp;Issuance of Series B Convertible <br> Perpetual Preferred Stock | 300 | 293475 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Accrued dividends on Series B <br> Convertible Perpetual Preferred Stock |  | 583 |  |  | (583) |  |  | (583) |
| &nbsp;&nbsp;&nbsp;Issuance of Common Stock |  |  |  |  | 155 |  |  | 155 |
| &nbsp;&nbsp;&nbsp;Share repurchase |  |  | (105) |  | (1103) |  |  | (1103) |
| &nbsp;&nbsp;&nbsp;Equity-based compensation |  |  | 406 |  | 6411 |  |  | 6411 |
| &nbsp;&nbsp;&nbsp;Reclassification of warrant liability to equity |  |  |  |  | 233 |  |  | 233 |
| &nbsp;&nbsp;&nbsp;Cumulative translation adjustment |  |  |  |  |  | (215) |  | (215) |
| &nbsp;&nbsp;&nbsp;Net loss |  |  |  |  |  |  | (144240) | (144240) |
| **Balance, June 30, 2025** | **300** | **294058** | **179836** | **180** | **867706** | **(231)** | **(768784)** | **98871** |
| &nbsp;&nbsp;&nbsp;Accrued dividends on Series B <br> Convertible Perpetual Preferred <br> Stock |  | 5344 |  |  | (5344) |  |  | (5344) |
| &nbsp;&nbsp;&nbsp;Series B Convertible Perpetual <br> Preferred Stock issuance costs |  | (98) |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Issuance of Common Stock |  |  |  |  | 155 |  |  | 155 |
| &nbsp;&nbsp;&nbsp;Warrants exercised |  |  | 106 |  | 1751 |  |  | 1751 |
| &nbsp;&nbsp;&nbsp;Share repurchase |  |  | (126) |  | (1727) |  |  | (1727) |
| &nbsp;&nbsp;&nbsp;Equity-based compensation |  |  | 375 |  | 2903 |  |  | 2903 |
| &nbsp;&nbsp;&nbsp;Cumulative translation adjustment |  |  |  |  |  | (20) |  | (20) |
| &nbsp;&nbsp;&nbsp;Net loss |  |  |  |  |  |  | (28370) | (28370) |
| **Balance, September 30, 2025** | **300** | $**299304** | **180191** | $**180** | $**865444** | $**(251)** | $**(797154)** | $**68219** |

---

*The accompanying notes are an integral part of these condensed consolidated financial statements.*

------

**PureCycle Technologies, Inc.**

**CONDENSED CONSOLIDATED STATEMENTS OF MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY**

**(Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **For the Three and Nine Months Ended September 30, 2024** | **For the Three and Nine Months Ended September 30, 2024** | **For the Three and Nine Months Ended September 30, 2024** | **For the Three and Nine Months Ended September 30, 2024** | **For the Three and Nine Months Ended September 30, 2024** | **For the Three and Nine Months Ended September 30, 2024** | **For the Three and Nine Months Ended September 30, 2024** | **For the Three and Nine Months Ended September 30, 2024** |
|  | **Mezzanine Equity** | **Mezzanine Equity** | **Stockholders' Equity** | **Stockholders' Equity** | **Stockholders' Equity** | **Stockholders' Equity** | **Stockholders' Equity** | **Stockholders' Equity** |
|  | **Series B Convertible Perpetual Preferred Stock** | **Series B Convertible Perpetual Preferred Stock** | **Common Stock** | **Common Stock** | **Additional Paid-in Capital** | **Accumulated Other Comprehensive (Loss)/Income** | **Accumulated Deficit** | **Total Stockholders' Equity** |
| ***(in thousands)*** | **Shares** | **Amount** | **Shares** | **Amount** |  |  |  |  |
| **Balance, December 31, 2023** |  | $**—** | **164279** | $**164** | $**764344** | $**(32)** | $**(344240)** | $**420236** |
| &nbsp;&nbsp;&nbsp;Issuance of Common Stock |  |  | 16 |  | 92 |  |  | 92 |
| &nbsp;&nbsp;&nbsp;Share repurchase |  |  | (99) |  | (598) |  |  | (598) |
| &nbsp;&nbsp;&nbsp;Equity-based compensation |  |  | 416 | 1 | 2681 |  |  | 2682 |
| &nbsp;&nbsp;&nbsp;Unrealized gain on available for <br> sale debt securities |  |  |  |  |  | 18 |  | 18 |
| &nbsp;&nbsp;&nbsp;Cumulative translation adjustment |  |  |  |  |  | 16 |  | 16 |
| &nbsp;&nbsp;&nbsp;Net loss |  |  |  |  |  |  | (85607) | (85607) |
| **Balance, March 31, 2024** |  | **—** | **164612** | **165** | **766519** | **2** | **(429847)** | **336839** |
| &nbsp;&nbsp;&nbsp;Share repurchase |  |  | (14) |  | (97) |  |  | (97) |
| &nbsp;&nbsp;&nbsp;Equity-based compensation |  |  | 148 |  | 3072 |  |  | 3072 |
| &nbsp;&nbsp;&nbsp;Cumulative translation adjustment |  |  |  |  |  | 9 |  | 9 |
| &nbsp;&nbsp;&nbsp;Net loss |  |  |  |  |  |  | (48212) | (48212) |
| **Balance, June 30, 2024** |  | **—** | **164746** | **165** | **769494** | **11** | **(478059)** | **291611** |
| &nbsp;&nbsp;&nbsp;Issuance of Common Stock |  |  | 8529 | 8 | 38102 |  |  | 38110 |
| &nbsp;&nbsp;&nbsp;Share repurchase |  |  | (87) |  | (483) |  |  | (483) |
| &nbsp;&nbsp;&nbsp;Equity-based compensation |  |  | 306 |  | 2883 |  |  | 2883 |
| &nbsp;&nbsp;&nbsp;Cumulative translation adjustment |  |  |  |  |  | (66) |  | (66) |
| &nbsp;&nbsp;&nbsp;Net loss |  |  |  |  |  |  | (90639) | (90639) |
| **Balance, September 30, 2024** |  | $**—** | **173494** | $**173** | $**809996** | $**(55)** | $**(568698)** | $**241416** |

---

*The accompanying notes are an integral part of these condensed consolidated financial statements.*

------

**PureCycle Technologies, Inc.**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
|  | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| ***(in thousands)*** | **2025** | **2024** |
| **Cash flows from operating activities** |  |  |
| Net loss | $(163778) | $(224458) |
| &nbsp;&nbsp;&nbsp;*Adjustments to reconcile net loss to net cash used in operating activities* |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity-based compensation | 12668 | 8637 |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of warrants | 1881 | 54532 |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of derivative | (3443) | 395 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation expense | 21875 | 23853 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of debt issuance costs and debt discounts | 17335 | 10505 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accretion of discount on debt securities |  | (330) |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease amortization expense | 3398 | 2281 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on extinguishment of debt |  | 21214 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on disposal of equipment | 3765 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Impairment of operating right-of-use asset |  | 757 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | 938 |  |
| &nbsp;&nbsp;&nbsp;*Changes in operating assets and liabilities* |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | (1595) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventory | (2638) | (1829) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | (1779) | (347) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other noncurrent assets | 968 | (63) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | (2062) | 675 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses and other current liabilities | (578) | (3379) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued interest | 1820 | (3334) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other noncurrent liabilities |  | 33 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease right-of-use liabilities | (2827) | (2127) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in operating activities | (114052) | (112985) |
| **Cash flows from investing activities** |  |  |
| &nbsp;&nbsp;&nbsp;Purchase of property, plant and equipment | (27504) | (33989) |
| &nbsp;&nbsp;&nbsp;Purchase of debt securities, available for sale |  | (30586) |
| &nbsp;&nbsp;&nbsp;Sale and maturity of debt securities, available for sale |  | 79161 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash (used in)/provided by investing activities | (27504) | 14586 |
| **Cash flows from financing activities** |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from issuance of Series B Convertible Perpetual Preferred Stock | 300000 |  |
| &nbsp;&nbsp;&nbsp;Proceeds from issuance of Series A Preferred shares, inclusive of put option |  | 21840 |
| &nbsp;&nbsp;&nbsp;Proceeds from issuance of Common Stock | 33462 | 38110 |
| &nbsp;&nbsp;&nbsp;Proceeds from issuance of revenue bonds to third parties | 16808 | 8000 |
| &nbsp;&nbsp;&nbsp;Proceeds from issuance of revenue bonds to related parties | 10063 | 40000 |
| &nbsp;&nbsp;&nbsp;Payments on related party revenue bonds | (535) | (475) |
| &nbsp;&nbsp;&nbsp;Payment to purchase revenue bonds |  | (253230) |
| &nbsp;&nbsp;&nbsp;Proceeds from revolving credit facility and related party note payable | 14900 |  |
| &nbsp;&nbsp;&nbsp;Payments on revolving credit facility and related party note payable | (14900) |  |
| &nbsp;&nbsp;&nbsp;Proceeds from exercise and issuance of warrants | 6616 | 30050 |
| &nbsp;&nbsp;&nbsp;Proceeds from equipment lease financing |  | 9536 |
| &nbsp;&nbsp;&nbsp;Payments on equipment financing | (7663) | (3118) |
| &nbsp;&nbsp;&nbsp;Preferred stock and debt issuance costs | (7624) | (1119) |
| &nbsp;&nbsp;&nbsp;Payments to repurchase shares | (4527) | (1178) |
| &nbsp;&nbsp;&nbsp;Other financing activities | 698 | 1122 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by/(used in) financing activities | 347298 | (110462) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net increase/(decrease) in cash and restricted cash | 205742 | (208861) |
| Cash and cash equivalents and restricted cash, beginning of period | 41511 | 302514 |
| Cash and cash equivalents and restricted cash, end of period | $247253 | $93653 |
| **Supplemental disclosure of cash flow information** |  |  |
| &nbsp;&nbsp;&nbsp;***Operating activities*** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest paid during the period | $29247 | $33786 |
| &nbsp;&nbsp;&nbsp;***Non-cash investing activities*** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Additions to property, plant, and equipment in accounts payable and accrued expenses | 13466 | 19546 |
| &nbsp;&nbsp;&nbsp;***Non-cash financing activities*** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;PIK dividends on Series B Convertible Perpetual Preferred Stock | 5927 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;PIK interest on Series A Preferred Stock | 3005 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Carrying value of shareholder loan exchanged for revenue bonds payable to related parties |  | 44386 |
| &nbsp;&nbsp;&nbsp;&nbsp;Initial fair value of warrant liability issued to satisfy shareholder loan prepayment penalty |  | 6802 |
| &nbsp;&nbsp;&nbsp;&nbsp;PIK interest on related party note payable |  | 1938 |
| **Reconciliation of cash and cash equivalents and restricted cash reported in the consolidated balance sheet** | **Reconciliation of cash and cash equivalents and restricted cash reported in the consolidated balance sheet** | **Reconciliation of cash and cash equivalents and restricted cash reported in the consolidated balance sheet** |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $234359 | $83673 |
| &nbsp;&nbsp;&nbsp;Restricted cash - current | 3582 | 241 |
| &nbsp;&nbsp;&nbsp;Restricted cash - noncurrent | 9312 | 9739 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total cash and cash equivalents and restricted cash | $247253 | $93653 |

---

*The accompanying notes are an integral part of these condensed consolidated financial statements.*

------

**PureCycle Technologies, Inc.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS** 

**(Unaudited)**

**NOTE 1 - ORGANIZATION**

PureCycle Technologies, Inc. and its consolidated subsidiaries ("PCT" or the "Company") is a Florida-based corporation focused on commercializing a patented purification recycling technology (the "Technology"), originally developed by The Procter & Gamble Company ("P&G"), for restoring waste polypropylene into resin, called PureFive™ resin, which has similar properties and applicability for reuse as virgin polypropylene. PCT has a global license for the Technology from P&G. PCT's goal is to introduce an important new product to the global polypropylene market that will assist multinational corporations in meeting their sustainability goals as well as federal and state regulations and mandates, providing consumers with polypropylene-based products that are sustainable, and reducing overall polypropylene waste in the world's landfills and oceans.

**NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**

***Basis of Presentation***

The accompanying condensed consolidated financial statements include the accounts of the Company and its consolidated subsidiaries. The condensed consolidated financial statements are presented in U.S. Dollars. Certain information in footnote disclosures normally included in annual financial statements was condensed or omitted for the interim periods presented in accordance with the rules and regulations of the Securities and Exchange Commission ("SEC") and accounting principles generally accepted in the United States of America ("U.S. GAAP"). Intercompany balances and transactions were eliminated upon consolidation. The accompanying condensed consolidated financial statements reflect all adjustments, consisting of normal recurring adjustments, that are, in the opinion of management, necessary to present a fair statement of the results for the interim periods presented.

The unaudited condensed consolidated financial statements should be read in conjunction with the information contained in the Annual Report on Form 10-K for the year ended December 31, 2024. The results of operations for the nine months ended September 30, 2025 are not necessarily indicative of the results to be expected for the entire year ending December 31, 2025.

***Reclassifications***

Certain amounts in prior periods have been reclassified to conform with the current year presentation.

***Restricted Cash***

Cash pledged as collateral for future capital purchases and leased properties is deemed restricted and included within this definition. Restricted cash that is expected to be spent or released from restriction within twelve months is classified as current on the Condensed Consolidated Balance Sheets. Restricted cash that is expected to be spent or released from restriction after twelve months is classified as noncurrent on the Condensed Consolidated Balance Sheets.

------

**PureCycle Technologies, Inc.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED**

**(Unaudited)**

***Revenue Recognition***

The Company's revenue is primarily generated from the sale of finished products or byproducts to customers. Those sales predominantly contain a single performance obligation and revenue is recognized at the point in time when control of the product is transferred to customers, along with the title, risk of loss and rewards of ownership. Depending on the arrangement with the customer, these criteria are met either at the time the product is shipped or when the product is made available or delivered to the destination specified in the agreement with the customer. Sales revenue is recognized in an amount that reflects the consideration the Company expects to be entitled to in exchange for that finished product. Amounts billed to customers related to freight are included in revenues and freight costs are included in cost of operations in the accompanying Condensed Consolidated Statements of Comprehensive Loss.

***Use of Estimates***

The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, the related disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of expenses for the period presented. The Company's most significant estimates and judgments involve valuation of the Company's liability-classified warrants and the related fair value assumptions. Although these estimates are based on management's best knowledge of current events and actions that the Company may undertake in the future, actual results may be different from these estimates.

***Segment Information***

Under Accounting Standards Codification ("ASC") 280, *Segment Reporting*, operating segments are defined as components of an enterprise where discrete financial information is available that is evaluated regularly by the chief operating decision maker ("CODM"), in deciding how to allocate resources and in assessing performance. Therefore, the Company's Chief Executive Officer, who is also the CODM, makes decisions and manages the Company's operations as a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins. To date, the Company has limited operations and measures performance on a consolidated basis. Management has determined that the measure of segment performance determined most in accordance with U.S. GAAP is consolidated net income or loss, as applicable. The Company's Condensed Consolidated Statements of Comprehensive Loss include the significant expense categories provided to the CODM on a consolidated basis, and the CODM does not review significant classifications of expenses outside of those shown on the Condensed Consolidated Statements of Comprehensive Loss. The CODM primarily reviews certain operating key performance indicators for evaluating performance and allocating resources.

***Recently Issued Accounting Pronouncements***

In September 2025, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2025-06 - *Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software.* The amendment simplifies the capitalization guidance by removing all references to software development project stages so that the guidance is neutral to different software development methods. The amendments to this update are effective for annual reporting periods beginning after December 15, 2027, and interim periods within those annual reporting periods. Early adoption of this update is permitted. The Company does not expect this guidance to have a material impact on its financial statements and disclosures.

------

**PureCycle Technologies, Inc.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED**

**(Unaudited)**

In November 2024, the FASB issued ASU No. 2024-04 – *Debt – Debt with Conversion and Other Options: Induced Conversions of Convertible Debt Instruments*, which improves the relevance and consistency in application of the induced conversion guidance in Subtopic 470-20, *Debt-Debt with Conversion and Other Options*. Specifically, the guidance is intended to clarify how to determine whether a settlement of convertible debt (particularly cash convertible instruments) at terms that differ from the original conversion terms should be accounted for under the induced conversion or extinguishment guidance. The amendments in this update are effective for all entities for annual reporting periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods. Early adoption is permitted for all entities that have adopted the amendments in ASU 2020-06. The Company is currently evaluating the impact that the updated standard will have on its financial statements.

In November 2024, the FASB issued ASU No. 2024-03, *Income Statement – Reporting Comprehensive Income – Disaggregation Disclosures*. In January 2025, the FASB issued ASU 2025-01, *Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date*. This guidance requires more detailed disclosure about the types of expenses presented within the expense captions of the financial statements. Specifically, disclosure of purchases of inventory, employee compensation, depreciation, and intangible asset amortization are required on both an interim and annual basis. In addition, a qualitative description of remaining amounts in relevant expense captions that have not separately been disaggregated will be required on an interim and annual basis. On an annual basis, disclosure of an entity's definition of selling expenses and the amount of selling expenses is required. The amendments to this update are effective for annual reporting periods beginning after December 15, 2026, and interim periods beginning after December 15, 2027. Early adoption of this update is permitted. The Company is currently evaluating the impact that the updated standard will have on its financial statements.

In December 2023, the FASB issued ASU 2023-09 - *Income Taxes (Topic 740): Improvements to Income Tax Disclosures,* which enhances the transparency and decision usefulness of income tax disclosures. The amendments in this update address investor requests for more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information and includes certain other amendments to improve the effectiveness of income tax disclosures. The updated standard is effective for annual periods beginning after December 15, 2024. Early adoption is permitted. The Company will adopt this guidance for its annual period ending December 31, 2025, which will include the expanded disclosures.

**NOTE 3 - LIQUIDITY AND GOING CONCERN**

The Company has determined that the going concern conclusion as previously disclosed in Note 2 to the condensed consolidated financial statements included in its quarterly filing on Form 10-Q for the period ended March 31, 2025 is no longer applicable for at least the twelve-month period from the issuance date of these financial statements. In the Form 10-Q filing for the period ended March 31, 2025, the Company disclosed there were conditions that raised substantial doubt about the Company's ability to continue as a going concern within one year after the date that the financial statements were issued. Those conditions were alleviated by management's plans, as outlined in that Form 10-Q filing.

The improvement in the Company's financial condition is attributable to the Company raising proceeds from the sale of the Series B Convertible Perpetual Preferred Stock, as described below and in more detail in Note 11 - *Mezzanine Equity and Stockholders' Equity*.

------

**PureCycle Technologies, Inc.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED**

**(Unaudited)**

In June 2025, the Company entered into binding subscription agreements with certain investors, including related parties, to which the Company agreed to sell to the investors, in a private placement transaction, an aggregate of 300,000 shares of the Company's Series B Convertible Perpetual Preferred Stock, par value $0.001 per share, at an initial issue price of $1,000 per share. The gross proceeds to the Company from these subscription agreements were approximately $300.0 million before deducting fees and expenses.

This development has led management to conclude that the previous substantial doubt about the Company's ability to continue as a going concern for a twelve-month period following the date that these financial statements were available to be issued is no longer present. The Company's current financial projections support the Company's ability to meet its obligations as they become due for at least one year from the issuance of these financial statements. The Company's ability to continue as a going concern longer term is dependent on continued improvement in operations at the Company's first commercial-scale recycling facility in Lawrence County, Ohio (the "Ironton Facility"), the commercialization of its PureFive<sup>TM</sup> resin product, and the successful construction and sale of product from its future Thailand and Antwerp facilities. Management continues to evaluate different strategies and may pursue additional actions to further increase its liquidity position.

**NOTE 4 - RELATED PARTY TRANSACTIONS**

The Company identifies and discloses transactions with related parties in accordance with ASC 850, *Related Party Disclosures*. The Company's related party transactions are primarily related to financing activities.

The Company's condensed consolidated financial statements reflect transactions with certain principal owners of PCT and their affiliates, including Sylebra Capital Management ("Sylebra"), Samlyn Capital, LLC ("Samlyn"), Pure Plastic LLC ("Pure Plastic"), and Pure Crown LLC ("Pure Crown"). The Company's condensed consolidated financial statements also reflect transactions with companies affiliated with PCT, including Glockner Family Venture Fund LP, Glockner Enterprises, and Glockner Oil (collectively, "Glockner"), as well as Milliken & Company ("Milliken").

PCT purchased $0.3 million and $0.8 million of certain chemicals used in its purification process from Milliken during the three and nine months ended September 30, 2025, respectively.

PCT currently has a $200.0 million Revolving Credit Facility (the "Revolving Credit Facility") pursuant to a credit agreement with Sylebra. On May 28, 2025, the Company borrowed $10.0 million from the Revolving Credit Facility. Borrowings under the Revolving Credit Facility accrued interest at a rate of 21.8%. The Company repaid the $10.0 million in borrowings plus accrued interest of $0.2 million on June 20, 2025. On November 4, 2025, the Company entered into the Tenth Amendment to the Revolving Credit Agreement, which extended the maturity date of the Revolving Credit Facility from September 30, 2026 to September 30, 2027 and added a clause regarding the potential redemption of Series A Preferred Stock. If, on or prior to March 17, 2026, sufficient proceeds are received from the exercise of Series A Warrants and the Board of Directors approve, then the Company shall redeem in full the Series A Preferred Stock. The Company incurred $1.0 million in fees for this amendment. Refer to Note 8 - *Long-Term Debt and Bonds Payable* for further information.

During June 2025, the Company executed a 30-day promissory note with Pure Plastic for $4.9 million at a rate of 1.0% interest per month. The promissory note was repaid on June 20, 2025 along with accrued interest in the amount of $0.02 million.

During the nine months ended September 30, 2025, the Company sold $11.4 million in aggregate par amount of Series A Bonds owned by PCT LLC to related parties at a purchase price of $880 per $1,000 principal amount under a bond purchase agreement for gross proceeds of $10.1 million. Refer to Note 8 *- Long-Term Debt and Bonds Payable* for further information.

------

**PureCycle Technologies, Inc.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED**

**(Unaudited)**

During June 2025, the Company entered into binding subscription agreements with certain investors, including investment entities affiliated with Sylebra, Samlyn, and Pure Crown, pursuant to which the Company agreed to sell in a private placement transaction shares of the Company's Series B Convertible Perpetual Preferred Stock, as further described in Note 11 - *Mezzanine Equity and Stockholders' Equity*.

During the three and nine months ended September 30, 2025, the Company issued 4,003 shares of its Series A Preferred Stock (as defined below) for in kind payment of dividends on the instruments, 2,001 of which were issued to Sylebra, and 2,002 were issued to Samlyn.

On July 28, 2025, Glockner, a related party of the Company, exercised 0.1 million of their outstanding Series A Warrants. The Company received $1.2 million in cash and issued 0.1 million shares of the Company's Common Stock, par value $0.001 per share ("Common Stock") to Glockner.

The table below summarizes the related party balances and transactions reflected in the condensed consolidated financial statements as of September 30, 2025 and December 31, 2024:

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
|  | **Sylebra** | **Samlyn** | **Pure Plastic** | **Pure Crown LLC** | **Glockner** | **Sylebra** | **Samlyn** | **Pure Plastic** | **Pure Crown LLC** | **Glockner** |
| ***Debt Instruments <br> (dollars in thousands)*** |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Related Party Bonds Payable *(Note 8)* | $785 | $3900 | $112045 | $— | $— | $— | $— | $105830 | $— | $— |
| **Preferred stock and warrants <br> *(shares in thousands)*** |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Series A Preferred Stock *(Note 11)* | 27 | 27 |  |  |  | 25 | 25 |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Series B Convertible Perpetual Preferred Stock *(Note 11)* | 40 | 50 |  | 5 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Series A Warrants *(Note 13)* | 10250 | 2857 |  | 1071 | 614 | 10250 | 2857 |  | 1071 | 714 |
| &nbsp;&nbsp;&nbsp;&nbsp;Series B Warrants *(Note 13)* |  |  | 3064 |  |  |  |  | 3064 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Series C Warrants *(Note 13)* | 2500 | 2500 |  |  |  | 2500 | 2500 |  |  |  |

---

**NOTE 5 - INVENTORY**

The Company's inventory is as follows:

---

| | | |
|:---|:---|:---|
| ***(in thousands)*** | **September 30, 2025** | **December 31, 2024** |
| Raw materials | $5487 | $4485 |
| Work in process | 370 | 824 |
| Finished goods | 4868 | 2778 |
| &nbsp;&nbsp;&nbsp;Total inventory | $10725 | $8087 |

---

------

**PureCycle Technologies, Inc.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED**

**(Unaudited)**

**NOTE 6 – PROPERTY, PLANT AND EQUIPMENT**

Presented in the table below are the major classes of property, plant and equipment by category as of the below dates:

---

| | | | |
|:---|:---|:---|:---|
| ***(dollars in thousands)*** | **Estimated Useful Life (Years)** | **September 30, 2025** | **December 31, 2024** |
| Building | 10 - 40 | $82026 | $82026 |
| Machinery and equipment | 3 - 30 | 373849 | 374639 |
| Leasehold improvements | 2 - 5 | 4829 | 4829 |
| Fixtures and furnishings | 5 - 7 | 764 | 800 |
| Land improvements | 15 | 150 | 150 |
| Land | Indefinite | 1150 | 1150 |
| Construction in process | N/A | 269853 | 266258 |
| &nbsp;&nbsp;&nbsp;Total property, plant and equipment at cost |  | 732621 | 729852 |
| &nbsp;&nbsp;&nbsp;Less: Accumulated depreciation |  | (76647) | (55773) |
| Property, plant, and equipment, net |  | $655974 | $674079 |

---

Depreciation expense is recorded in the Condensed Consolidated Statements of Comprehensive Loss as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| ***(in thousands)*** | **2025** | **2024** | **2025** | **2024** |
| Cost of operations | $6457 | $6425 | $19429 | $20981 |
| Research and development expense | 773 | 759 | 2320 | 2284 |
| Selling, general and administrative expense | 32 | 246 | 126 | 588 |
| &nbsp;&nbsp;&nbsp;Total depreciation expense | $7262 | $7430 | $21875 | $23853 |

---

**NOTE 7 - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES**

The Company's accrued expenses and other current liabilities are as follows:

---

| | | |
|:---|:---|:---|
| ***(in thousands)*** | **September 30, 2025** | **December 31, 2024** |
| Accrued purchases | $17562 | $39078 |
| Accrued lease obligations | 3823 | 3289 |
| Employee-related costs | 2019 | 698 |
| Other | 90 | 194 |
| &nbsp;&nbsp;&nbsp;Total other current liabilities | $23494 | $43259 |

---

------

**PureCycle Technologies, Inc.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED**

**(Unaudited)**

**NOTE 8 – LONG-TERM DEBT AND BONDS PAYABLE**

The Company's debt balances, including related party debt, consist of the following at September 30, 2025 and December 31, 2024:

---

| | | |
|:---|:---|:---|
| ***(in thousands)*** | **September 30, 2025** | **December 31, 2024** |
| **<u>Long-term Debt</u>** |  |  |
| Green Convertible Notes, interest at 7.25% due semiannually; balance due at maturity in August 2030 | $250000 | $250000 |
| CSC Equipment Financing Payable, currently bearing interest at a monthly charge of 3.1% of the outstanding balance financed; 36-month term expected to commence on or about the fourth quarter of 2028, bearing interest at 7.25% (based on lease rate factor indexed to WSJ Prime Rate) <sup>(1)</sup> | 16516 | 19066 |
| Revenue Bonds, interest at 7% due semiannually; semiannual principal repayments beginning 2031 maturing 2042 | 31900 | 12800 |
| Other Debt | 9646 | 12425 |
|  | 308062 | 294291 |
| Less: Original issue discount and debt issuance costs classified as a reduction to long-term debt | (20920) | (24473) |
| Less: Current portion | (10289) | (12932) |
| &nbsp;&nbsp;&nbsp;**Long-term debt, less current portion** | $**276853** | $**256886** |
| **<u>Related Party Bonds Payable</u>** |  |  |
| Revenue Bonds due to related party, interest rates between 6.5% and 13% due semiannually; principal repayments vary by series and began June 30, 2024, fully maturing December 2042 | 116730 | 105830 |
| Less: Original issue discount and debt issuance costs classified as a reduction to note payable | (24785) | (29004) |
| Less: Current portion | (13540) | (10355) |
| &nbsp;&nbsp;&nbsp;**Related party debt, less current portion** | $**78405** | $**66471** |
| Sylebra Line of Credit, $200.0 million borrowing capacity remaining, interest at SOFR plus 17.5% at September 30, 2025 and December 31, 2024; maturing September 2027 | $— | $— |

---

__________

<sup>(1)</sup> During October 2025, the Company paid off the entire outstanding balance of the CSC Equipment Financing Payable and recorded a loss on extinguishment of approximately $4.4 million as noted in Note 16 - *Subsequent Events*.

***Revenue Bonds***

In October 2020, the Southern Ohio Port Authority ("SOPA") issued certain Revenue Bonds (as defined below) pursuant to an Indenture of Trust dated as of October 1, 2020 (as amended, restated, supplemented or otherwise modified from time to time, the "Indenture of Trust"), between SOPA and UMB Bank, N.A., as trustee, and loaned the proceeds from their sale to PureCycle: Ohio LLC ("PCO"), an Ohio limited liability company and indirect wholly-owned subsidiary of the Company, pursuant to a Loan Agreement dated as of October 1, 2020, between SOPA and PCO (as amended, restated, supplemented or otherwise modified from time to time, the "Loan Agreement") to be used, among other things, to acquire, construct and equip a portion of the Company's first commercial-scale recycling facility in Ironton, Ohio. Capitalized terms used but not defined herein have the meanings ascribed thereto in the Indenture of Trust or the Loan Agreement.

------

**PureCycle Technologies, Inc.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED**

**(Unaudited)**

The Revenue Bonds were offered in three series, including (i) Exempt Facility Revenue Bonds (PureCycle Project), Tax-Exempt Series 2020A ("Series 2020A Bonds" or "Senior Bonds"); (ii) Subordinate Exempt Facility Revenue Bonds (PureCycle Project), Tax-Exempt Series 2020B ("Series 2020B Bonds"); and (iii) Subordinate Exempt Facility Revenue Bonds (PureCycle Project), Taxable Series 2020C ("Series 2020C Bonds" and, together with the Series 2020A Bonds and the Series 2020B Bonds, the "Bonds" or the "Revenue Bonds").

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Bond Series** | **Term** | **Principal Amount <br>*(in thousands)*** | **Outstanding as of September 30, 2025<br>*(in thousands)*** | **Interest Rate** | **Maturity Date** |
| 2020A | A1 | $12370 | $— | 6.25% | December 1, 2025 |
| 2020A | A2 | 38700 | 38700 | 6.50% | December 1, 2030 |
| 2020A | A3 | 168480 | 81445 | 7.00% | December 1, 2042 |
| 2020B | B1 | 10000 | 9460 | 10.00% | December 1, 2025 |
| 2020B | B2 | 10000 | 9460 | 10.00% | December 1, 2027 |
| 2020C | C1 | 10000 | 9565 | 13.00% | December 1, 2027 |
|  |  | $249550 | $148630 |  |  |

---

In March 2024, PureCycle Technologies LLC ("PCT LLC"), a subsidiary of the Company, purchased 99% of the outstanding Revenue Bonds. PCT LLC has subsequently sold certain of these Revenue Bonds to various third parties.

During the nine months ended September 30, 2025, PCT LLC sold approximately $19.1 million in aggregate principal amount of its Senior Bonds to certain investors at a purchase price of $880 per $1,000 principal amount for gross proceeds of $16.8 million.

As of September 30, 2025, PCT LLC held $87.0 million of Senior Bonds that it intends to, and has the authority to, re-market based on the need for additional liquidity.

***Revenue Bonds Sold to Related Parties***

During the nine months ended September 30, 2025, PCT LLC sold $11.4 million in aggregate principal amount of its Senior Bonds to related parties at a purchase price of $880 per $1,000 principal amount for gross proceeds of $10.1 million.

***Sylebra Credit Facility***

PCT currently has a $200.0 million Revolving Credit Facility pursuant to a credit agreement (the "Revolving Credit Agreement") dated as of March 15, 2023 and amended from time to time, with PureCycle Technologies Holdings Corp. and PCT LLC (the "Guarantors"), Sylebra Capital Partners Master Fund, LTD, Sylebra Capital Parc Master Fund, and Sylebra Capital Menlo Master Fund (collectively, the "Lenders"), and Madison Pacific Trust Limited (the "Administrative Agent" and "Security Agent"). The Lenders and their affiliates are greater than 5% beneficial owners of PCT.

Amounts outstanding under the Revolving Credit Agreement bear interest at a variable annual rate equal to Term SOFR (as defined in the Revolving Credit Agreement) in effect for such period plus 17.50%. PCT is also required to pay a commitment fee equal to 0.25% per annum based on the actual daily unused amount of the Revolving Credit Facility, payable quarterly. Subject to timely prior written notice and payment of breakage fees, if any, PCT may at any time and from time to time (i) terminate all or any portion of the commitments under the Revolving Credit Agreement and/or (ii) prepay all or any portion of any outstanding borrowings.

------

**PureCycle Technologies, Inc.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED**

**(Unaudited)**

The Revolving Credit Agreement contains representations, covenants and events of default that are customary for financing transactions of this nature. Events of default in the Revolving Credit Agreement include, among others: (a) non-payment of principal, interest, fees or other amounts; (b) default of specific covenants; (c) breach of representations and warranties; (d) cross-defaults to other indebtedness in an amount greater than $1.0 million, subject to certain exceptions; (e) bankruptcy and insolvency proceedings; (f) inability to pay debts or attachment; (g) judgments; and (h) change of control. Upon the occurrence of an event of default, the Administrative Agent shall, at the request of, or may, with the consent of, the Required Lenders (as defined in the Revolving Credit Agreement) terminate the loan commitments, accelerate all loans and exercise on behalf of itself and the Lenders all rights and remedies available to it and the Lenders under the Revolving Credit Agreement and the other loan documents.

Amounts outstanding under the Revolving Credit Agreement are guaranteed by the Guarantors, and are secured by a security interest in substantially all of the assets of PCT. Any majority-owned direct or indirect subsidiaries of PCT are required to guaranty the obligations under the Revolving Credit Agreement and grant security interests in substantially all of their respective assets.

On February 5, 2025, in conjunction with a private placement offering of the Company's Common Stock, the Company, the Guarantors, the Administrative Agent, the Security Agent and the Lenders executed a Limited Consent and Seventh Amendment to the Credit Agreement to, among other things, permit the offering and the transactions contemplated thereby. The lenders and their affiliates are greater than 5% beneficial owners of the Company.

On April 11, 2025, the Company entered into the Eighth Amendment to the Revolving Credit Agreement, which extended the maturity date of the Revolving Credit Facility from March 31, 2026 to September 30, 2026.

On June 16, 2025, in conjunction with a private placement offering of the Company's Series B Convertible Perpetual Preferred Stock, the Company, the Guarantors, the Administrative Agent, the Security Agent and the Lenders executed a Ninth Amendment to the Credit Agreement to, among other things, (i) permit the offering of the Company's Series B Convertible Perpetual Preferred Stock, and (ii) amend the indebtedness covenant to add a basket for unsecured indebtedness of the Company in an aggregate principal amount not to exceed $50.0 million.

During June 2025, the Company drew a total of $10.0 million on the Revolving Credit Facility, which was repaid during the same month using the funds received on the Series B Preferred Convertible Perpetual Preferred Stock, as described in more detail in Note 11 - *Mezzanine Equity and Stockholders' Equity*.

On November 4, 2025, the Company entered into the Tenth Amendment to the Revolving Credit Agreement, which extended the maturity date of the Revolving Credit Facility from September 30, 2026 to September 30, 2027 and added a clause regarding the potential redemption of Series A Preferred Stock. If, on or prior to March 17, 2026, sufficient proceeds are received from the exercise of Series A Warrants and the Board of Directors approve, then the Company shall redeem in full the Series A Preferred Stock.

There were no funds drawn on the Revolving Credit Facility as of September 30, 2025 and December 31, 2024, respectively.

***Green Convertible Notes***

On August 21, 2023, the Company priced its private offering of $215.0 million in aggregate principal amount of 7.25% Green Convertible Senior Notes due 2030 (the "Initial Notes"). On August 22, 2023, the initial purchaser in such offering exercised its option to purchase an additional $35.0 million in aggregate principal amount of the 7.25% Green Convertible Senior Notes due 2030 (together with the "Initial Notes", the "Green Convertible Notes"), bringing the total aggregate principal amount of the Green Convertible Notes to $250.0 million. Entities affiliated with a

------

**PureCycle Technologies, Inc.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED**

**(Unaudited)**

greater than 5% beneficial owner of the Company purchased $50.0 million aggregate principal amount at maturity of the Green Convertible Notes. Refer to Note 14 - *Fair Value of Financial Instruments* for further information.

On August 24, 2023, the Company completed the private offering of the Green Convertible Notes. Each $1,000 principal amount at maturity of the Notes was issued at a price of $900. An amount equal to the difference between the issue price and the principal amount at maturity will accrete from the original issue date through August 15, 2027. The Notes are senior unsecured obligations of the Company.

The net proceeds from the Green Convertible Notes, excluding any offering expenses, were approximately $218.5 million, after deducting the initial purchaser's discounts and fees paid to the Company's financial advisor. The Company allocated an amount equal to the net proceeds from the offering to the financing and refinancing of recently completed and future Eligible Green Projects (as defined below) in the United States. In particular, the Company allocated the net proceeds from the offering (1) to make payments on certain long-lead items (2) to fund initial inside and outside battery limits engineering design work, all of which are associated with a multi-line purification facility to be built in Augusta, Georgia (the "Augusta Facility"), (3) for certain feedstock preparation ("PreP") equipment and (4) to a research and development lab.

This allocation included historical spend from January 1, 2022, through December 31, 2024, related to the Augusta Facility, as well as the PreP facilities in process that will provide feedstock for both the Augusta Facility and also the Ironton Facility.

In June 2025, the Company announced its intent to re-direct and re-purpose certain previously purchased long-lead equipment valued at $195 million to its projects in Antwerp, Belgium and/or Rayong, Thailand. The Company also announced its intent to design a larger capacity facility, the first of which is to be constructed and installed at the Augusta Facility. The Company has already allocated $62 million toward certain PreP equipment and a research and development lab, and will use additional funds, significantly in excess of the remaining unallocated proceeds from the Green Convertible Notes, to continue engineering design work and to purchase additional long lead items for the Augusta Facility. Pending such allocation, the Company intends to use the remaining net proceeds for general corporate purposes.

"Eligible Green Projects" means: investments in (i) acquisitions of buildings; (ii) building developments or redevelopments; (iii) renovations in existing buildings; and (iv) tenant improvement projects, in each case, that have received, or are expected to receive, in the three years prior to the issuance of the Notes or during the term of the Notes, a Leadership in Energy and Environmental Design ("LEED") Silver, Gold or Platinum certification (or environmentally equivalent successor standards). Prior to issuing the Notes and as part of its overall business plan, the Company has focused on the value of the sustainability opportunities PureFive™ resin offers to support expanding a circular economy. To pursue those opportunities, the Company purchased equipment and commissioned design services for PreP facilities that will enable the Company to advance circular economy adapted products, production technologies and processes, and/or research and development related to recycling waste polypropylene. The Company believes those legacy purchases and designs should complement the Company's Eligible Green Projects development.

The Augusta Facility is currently in the front-end engineering and design validation phase and is incorporating the operational optimization and efficiency opportunities identified during the Ironton Facility commissioning. The Company identified "Building Design and Construction" as the appropriate LEED rating system for the Augusta Facility project though the Company believes it is premature to register the Augusta Facility project with the LEED on-line platform at this time.

------

**PureCycle Technologies, Inc.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED**

**(Unaudited)**

In connection with the issuance of the Green Convertible Notes, the Company entered into an Indenture, dated August 24, 2023 (the "Indenture"), with U.S. Bank Trust Company, National Association, as trustee. The Indenture includes customary covenants and sets forth certain events of default after which the Notes may be declared immediately due and payable and sets forth certain types of bankruptcy or insolvency events of default involving the Company after which the Notes become automatically due and payable. The events of default, as set forth in the Indenture and subject in certain cases to customary grace and cure periods, include customary events including a default in the payment of principal or interest, failure to comply with the obligation to deliver amounts due upon conversion, failure to give certain notices, failure to comply with the obligations in respect of certain merger transactions, defaults under certain other indebtedness and certain events of bankruptcy and insolvency.

The Green Convertible Notes will mature on August 15, 2030 (the "Maturity Date"), unless earlier repurchased, redeemed or converted. The Green Convertible Notes will bear interest at a rate of 7.25% per annum on the principal amount at maturity from August 24, 2023, payable semi-annually in arrears on February 15 and August 15 of each year, beginning on February 15, 2024.

Holders of the Green Convertible Notes may convert all or any portion of the Green Convertible Notes at their option at any time prior to the close of business on the second scheduled trading day immediately preceding the Maturity Date. Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of its Common Stock or a combination of cash and shares of its Common Stock, at the Company's election. The conversion rate will initially be 67.4764 shares of Common Stock per $1,000 principal amount at maturity of notes (equivalent to an initial conversion price of approximately $14.82 per share of Common Stock), which represents a conversion premium of approximately 50% to the $9.88 per share closing price of the Company's Common Stock on the Nasdaq Capital Market on August 21, 2023. The conversion rate will be subject to adjustment upon the occurrence of certain events. In addition, following certain corporate events described in the Indenture that occur prior to August 15, 2027, or upon the issuance of a notice of redemption (as described below) prior to August 15, 2027 for an optional redemption, the Company will, in certain circumstances, increase the conversion rate for a holder who elects to convert its Notes in connection with such a corporate event or elects to convert its notes called (or deemed called) for optional redemption during the related redemption period.

Holders of the Green Convertible Notes have the right to require the Company to repurchase for cash all or any portion of their Green Convertible Notes on August 15, 2027 at a repurchase price equal to 100% of the principal amount at maturity of the Notes to be repurchased, plus accrued and unpaid interest to, but excluding, August 15, 2027. In addition, if the Company undergoes a fundamental change (as defined in the Indenture), holders of the Notes may require the Company to repurchase their Notes at a cash repurchase price equal to 100% of the accreted principal amount of the Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date.

The Company may not redeem the Green Convertible Notes prior to August 20, 2025. The Company may redeem for cash all or any portion of the Green Convertible Notes (subject to certain exceptions and restrictions specified in the Indenture), at its option, on or after August 20, 2025 and on or before the 40th scheduled trading day immediately before the Maturity Date, at a cash redemption price equal to 100% of the accreted principal amount of the Green Convertible Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date, but only if the last reported sale price per share of the Company's Common Stock exceeds 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides a notice of redemption to the holders of the Green Convertible Notes. No sinking fund is provided for the Green Convertible Notes. The fair value of the Green Convertible Notes is included in the Level 3 measurement in the fair value hierarchy as they were derived using significant unobservable inputs. Refer to Note 14 - *Fair Value of Financial Instruments* for further information.

------

**PureCycle Technologies, Inc.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED**

**(Unaudited)**

The following provides a summary of the interest expense of the Company's Green Convertible Notes:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| ***(in thousands, except interest rate)*** | **2025** | **2024** | **2025** | **2024** |
| Contractual interest expense | $4531 | $4531 | $13594 | $13594 |
| Amortization of deferred financing costs | 399 | 357 | 1166 | 1043 |
| Amortization of original issue discount | 1537 | 1375 | 4485 | 4014 |
| Effective interest rate | 10.3% | 10.0% | 10.3% | 9.9% |

---

The following provides a summary of the Company's Green Convertible Notes:

---

| | | |
|:---|:---|:---|
| ***(in thousands)*** | **September 30,<br>2025** | **December 31,<br>2024** |
| Unamortized deferred issuance costs | $16772 | $22423 |
| Net carrying amount | 233228 | 227577 |

---

Principal repayments due on long-term debt and related party bonds payable over the next five years are as follows (in thousands):

---

| | | |
|:---|:---|:---|
| **Years Ending December 31,** | **Long-Term Debt** | **Related Party Bonds Payable** |
| 2025 (October through December) | $3183 | $9820 |
| 2026 | 7106 | 7570 |
| 2027 | 872 | 25105 |
| 2028 | 3549 | 7710 |
| 2029 | 4209 | 8220 |
| 2030 | 257243 | 8760 |
| Thereafter | 31900 | 49545 |
|  | 308062 | 116730 |
| Less: Original issue discount and debt issuance costs classified as a reduction to long-term debt | (20920) | (24785) |
| Less: Current portion | (10289) | (13540) |
| &nbsp;&nbsp;&nbsp;Total | $276853 | $78405 |

---

**NOTE 9 - INCOME TAXES**

The Company has determined that any net deferred tax assets are not more likely than not to be realized in the future, and a full valuation allowance is required. In addition, the Company has determined that any current forecasted operations would result in federal and state income tax losses that are also not more likely than not to be realized. As a result, the Company has no reported tax expense for both the three and nine months ended September 30, 2025 and 2024, respectively.

Management has evaluated the Company's tax positions and has determined that the Company has taken no uncertain tax positions that require adjustment to the condensed consolidated financial statements for the reported periods.

------

**PureCycle Technologies, Inc.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED**

**(Unaudited)**

**NOTE 10 - COMMITMENTS AND CONTINGENCIES**

***Financial Assurance***

The Company holds a surety bond in the amount of $8.1 million as of September 30, 2025 to provide financial assurance related to its performance under a certain vendor contract, which expires at the earlier of satisfaction of the obligation, termination of the related vendor contract, or one year from issuance (subject to renewal within one year).

***Legal Proceedings***

The Company is subject to legal and regulatory actions that arise from time to time in the ordinary course of business. The assessment as to whether a loss is probable or reasonably possible, and as to whether such loss or a range of such losses is estimable, often involves significant judgment about future events, and the outcome of litigation is inherently uncertain. Other than as described below, there is no material pending or threatened litigation against the Company that remains outstanding as of September 30, 2025.

***Denham-Blythe Arbitration***

On October 7, 2020, PCO, a subsidiary of the Company, and Denham-Blythe Company, Inc. ("DB"), executed an Engineering, Procurement, and Construction Agreement for certain construction activities associated with the Ironton Facility ("EPC Contract").

On June 16, 2023, following unsuccessful efforts at mediating various disputes over certain unapproved change orders and payment applications, DB filed a demand for binding arbitration ("Arbitration Demand") with the American Arbitration Association ("AAA"), seeking approximately $17.0 million plus attorney's fees and cost of the arbitration related to certain fee applications, change orders and amounts currently held in retainage by PCO, and, on June 21, 2023, filed a mechanics lien in Lawrence County, Ohio for the same sum. On July 20, 2023, PCO filed its Answer and Counterclaim, in which PCO contends that various deficiencies in DB's work resulted in damages to PCO in excess of DB's $17.0 million Arbitration Demand, including, but not limited to, the following: DB's late delivery, insufficient and incomplete engineering drawings and packages, insufficient and unorganized material management, insufficient and inefficient contractor management, insufficient and rudimentary schedule management, incomplete and inefficient procurement procedures, and that the Company was required to undertake significant re-work at additional cost resulting from DB's failure to adequately perform its obligations under the EPC Contract.

On August 30, 2023, DB filed a breach of contract claim against PCO and others in Lawrence County Ohio, alleging the same facts contained in its Arbitration Demand, as well as an action to foreclose on a lien filed in Lawrence County, Ohio. Concurrently DB requested the complaint be stayed pending the resolution of all issues in the arbitration.

On September 14, 2023, DB filed a motion with the AAA seeking to join ThermalTech Engineering, Inc., and ThermalTech Turnkey Solutions LLC, a subcontractor engaged by DB to provide engineering services and equipment procurement and installation for the Ironton Project. In an order dated December 7, 2023, the AAA granted DB's request to join ThermalTech Engineering, Inc., and ThermalTech Turnkey Solutions LLC (collectively, "TT"). Thereafter, TT filed an answer and counterclaim alleging DB failed to pay them approximately $2.0 million.

On March 8, 2024, ISC Constructors, a DB subcontractor ("ISC"), filed an action in equity for unjust enrichment against PCO in Lawrence Co. Ohio Case # 240C000171. The lawsuit alleges $0.5 million in unpaid invoices and retainage. The lawsuit ISC filed was consolidated with the pending DB claims and has been stayed pending completion of the arbitration. An arbitration claim for breach of contract, for the same amount, was filed by ISC

------

**PureCycle Technologies, Inc.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED**

**(Unaudited)**

Constructors in the AAA against DB. That arbitration action has been consolidated with the AAA arbitration between PCO and DB listed above. Recently, at ISC's request, the AAA separated the claims of ISC for a later hearing after the completion of the arbitration involving TT, DB and PCO.

PCO intends to vigorously defend itself against DB's claims and to pursue recovery of damages resulting from DB's failure to perform adequately under the EPC Contract. The arbitration hearing concluded in August 2025, and the parties await the decision of the arbitration panel; accordingly, PCT cannot reasonably estimate at this time whether there will be any loss, or if there is a loss, the possible range of loss, that may result from the Arbitration Demand.

***Other Matters***

On April 25, 2024, the Company received a litigation demand letter from a purported shareholder, Selim Piot, requesting that the Board of Directors ("Board") of the Company take action against certain officers and directors. On May 6, 2024, Mr. Piot served a books and records demand and initiated a derivative action in the Chancery Court of Delaware captioned Piot v. Bouck, et al., No. 2024 0475 NAC (Del. Ch.). On May 21, 2024, Mr. Piot served another books and records demand. The claims asserted in Mr. Piot's demand letters and derivative action are substantially similar to those asserted in the now resolved derivative lawsuits and other parties' books and records demand letters pursuant to Section 220 of the Delaware General Corporation laws. The parties agreed to a stipulation dismissing the Piot derivative action, and on July 23, 2025, the Court issued an order dismissing the Piot derivative action with prejudice.

**NOTE 11 - MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY**

**Mezzanine Equity**

***Series B Convertible Perpetual Preferred Stock***

On June 16, 2025, the Company entered into binding subscription agreements (the "Series B Subscription Agreements") with certain investors (collectively, the "Series B Investors"), including investment entities affiliated with Pure Crown, Sylebra, Daniel Gibson, and Samlyn, pursuant to which the Company agreed to sell to the Series B Investors, in a private placement transaction (the "Series B Offering"), an aggregate of 300,000 shares of Series B Convertible Perpetual Preferred Stock at an initial issue price of $1,000 per share. The transactions contemplated by the Series B Subscription Agreements closed on June 20, 2025 (the "Closing Date"). The gross proceeds to the Company were $300.0 million before deducting placement agent fees and other estimated offering expenses.

In accordance with ASC 480, *Distinguishing Liabilities from Equity*, the Company has classified the Series B Convertible Perpetual Preferred Stock in temporary (mezzanine) equity because the Company can be forced into a cash redemption scenario upon events not within its control pursuant to a change in control redemption provision. The Company initially measured the Series B Convertible Perpetual Preferred Stock at the amount of total proceeds less offering costs. Because the Series B Convertible Perpetual Preferred Stock is neither currently redeemable nor probable of becoming redeemable in the future, no subsequent measurement is required at this time. The Company will continue to monitor the probability of the Series B Convertible Perpetual Preferred Stock becoming redeemable at each reporting period.

The Series B Convertible Perpetual Preferred Stock was issued pursuant to a Series B Certificate of Designations (the "Series B Certificate of Designations") filed with the Secretary of State of the State of Delaware, establishing the preferences, limitations and relative rights of the Series B Convertible Perpetual Preferred Stock. The Series B Certificate of Designations amended the Company's Certificate of Incorporation and was effective immediately on filing.

------

**PureCycle Technologies, Inc.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED**

**(Unaudited)**

The Series B Convertible Perpetual Preferred Stock ranks, with respect to dividend rights and rights upon any liquidation, dissolution or winding up of the Company (a "Liquidation Event"): (a) senior to the Company's Common Stock and other capital stock of the Company, the terms of which do not expressly provide that such class or series ranks senior to or on a parity with the Series B Convertible Perpetual Preferred Stock other than the Company's Series A Preferred Stock, as to divided rights and rights upon Liquidation Events; (b) on a parity with any other class or series of capital stock of the Company, the terms of which expressly provide that such class or series ranks on a parity with the Series B Convertible Perpetual Preferred Stock as to dividend rights and rights upon Liquidation Events; (c) junior to the Series A Preferred Stock and any other class or series of capital stock of the Company, the terms of which expressly provide that such class or series ranks senior to the Series B Convertible Perpetual Preferred Stock as to dividend rights and rights upon Liquidation Events; and (d) junior to all existing and future indebtedness of the Company.

A holder of the Series B Convertible Perpetual Preferred Stock may elect to convert their holdings into shares of the Company's Common Stock at any time. In addition, on or after the dividend payment date following the fourth anniversary of the Closing Date, if at any time the closing price of the Company's Common Stock has been at least 175% of the applicable conversion price for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading days ending on the trading day immediately preceding the trading day on which a conversion notice is given (a "Series B Conversion Notice"), the Company may elect to convert all of the Series B Convertible Perpetual Preferred Stock into a number of shares of the Company's Common Stock equal to the Series B Accrued Value (as defined below) divided by the conversion price on the date of the Series B Conversion Notice, unless modified pursuant to a Make-Whole Change (as defined below). The Series B Convertible Perpetual Preferred Stock is convertible into the Company's Common Stock at an initial conversion price equal to $14.02, which represents a 30% premium to the 10-day volume weighted average price of the Company's Common Stock on the trading day immediately prior to the execution of the Series B Subscription Agreements.

If requisite stockholder approval is required for certain conversions, then until such approval is obtained, no shares of the Company's Common Stock will be issued or delivered upon conversion of Series B Convertible Perpetual Preferred Stock if doing so would cause the holder (or any related person/group) to own more than 19.99% of the outstanding voting stock.

Except as may be expressly required by the Delaware General Corporation Law, holders of the Series B Convertible Perpetual Preferred Stock are not entitled to any voting rights.

Holders of the Series B Convertible Perpetual Preferred Stock are entitled to receive cumulative dividends at a rate equal to 7% per annum, payable in kind or in cash at the Company's option, which dividends, if paid in kind, will be capitalized to the Series B Accrued Value. During the three and nine months ended September 30, 2025, there were $5.3 million and $5.9 million of in-kind dividends accrued on the Series B Convertible Perpetual Preferred stock, which increased the outstanding Series B Perpetual Convertible Preferred Stock value.

In the event of any Liquidation Event, each holder of the Series B Convertible Perpetual Preferred Stock will be entitled to receive a per share amount equal to the greater of (i) the per share purchase price of the Series B Convertible Perpetual Preferred Stock (as adjusted for any in-kind dividends paid thereon) plus all accrued and unpaid dividends thereon (the "Series B Accrued Value") and (ii) the amount that such Series B Convertible Perpetual Preferred Stock would have been entitled to receive if they had converted into the Company's Common Stock immediately prior to such Liquidation Event.

------

**PureCycle Technologies, Inc.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED**

**(Unaudited)**

The Company may not take any of the following actions unless otherwise approved by the holders of a majority of the then-outstanding Series B Convertible Perpetual Preferred Stock: (a) amend or waive any provision in the Certificate of Incorporation in any way that materially, adversely and disproportionately affects the rights, preferences, and privileges or power of the Series B Convertible Perpetual Preferred Stock; (b) increase the authorized number of shares of Series A Preferred Stock unless such increase is required pursuant to the existing terms of the Certificate of Designations of Series A Preferred Stock, as modified by the waivers entered into by all of the holders of the Series A Preferred Stock on September 17, 2024; (c) other than in connection with the Series A Preferred Stock, issue any equity securities of the Company containing rights, preferences or privileges with respect to distributions or liquidation superior to or on parity with the Series B Convertible Perpetual Preferred Stock; or (d) repurchase or redeem any of the Company's issued and outstanding Common Stock other than any such repurchases or redemptions (i) undertaken in connection with any equity incentive agreements approved by the Board, (ii) undertaken to satisfy obligations of the Company existing on the date of the Certificate of Designations or (iii) that do not result in payments by the Company in an aggregate amount, together with all prior payments made pursuant to this clause (iii), in excess of $50.0 million.

Except in the case of a change in control, the Series B Convertible Perpetual Preferred Stock may not be redeemed or repurchased upon the election of the holders of the Series B Convertible Perpetual Preferred Stock.

Upon certain change in control events involving the Company, (i) the holders of the Series B Convertible Perpetual Preferred Stock will have the right to require the Company to redeem any or all of their Series B Convertible Perpetual Preferred Stock and (ii) the Company will have the option to redeem all (but not less than all) of the then-outstanding Series B Convertible Perpetual Preferred Stock, in each case, for a cash amount equal to the Series B Accrued Value, on a per share basis. In connection with the Company delivering a Series B Conversion Notice or in connection with a change in control, the Company will, in certain circumstances, be required to increase the conversion rate for shares of Series B Convertible Perpetual Preferred Stock converting in connection therewith (a "Make-Whole Change"). Such Make-Whole Change will be calculated using a make-whole table calculated over a 10-year period. In no event will the conversion rate be increased to an amount that exceeds 87.5611 shares of Common Stock per $1,000 liquidation preference of Series B Preferred Stock.

In conjunction with the Series B Offering, the Company entered into the Ninth Amendment to the Company's Revolving Credit Facility, to, among other things, (i) permit the Series B Offering and (ii) amend the indebtedness covenant to add a basket for unsecured indebtedness of the Company in an aggregate principal amount not to exceed $50.0 million.

------

**PureCycle Technologies, Inc.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED**

**(Unaudited)**

**Stockholders' Equity**

***Preferred Transactions***

On September 11, 2024, the Company entered into subscription agreements (the "Series A Subscription Agreements") with certain investors (the "Series A Investors"), including affiliates of Sylebra and Samlyn, both related parties, pursuant to which the Company agreed to sell to the Series A Investors, in a private placement, an aggregate of (i) 50,000 shares of the Company's Series A Preferred Stock, par value $0.001 per share ("Series A Preferred Stock"), sold at an initial issue price of $1,000 per share, (ii) 8,528,786 shares of the Company's Common Stock, sold at a price of $4.69 per share (the "Common Stock Price"), and (iii) Series C Warrants to purchase an aggregate of 5,000,000 shares of the Company's Common Stock at a price of $11.50 per share of Common Stock (the "Series C Warrants", and the shares of Common Stock issuable upon exercise of the Series C Warrants, the "Warrant Shares"). The transactions contemplated by the Series A Subscription Agreements closed on September 13, 2024. The gross proceeds to the Company were approximately $90.0 million before deducting fees and other estimated offering expenses, which were immaterial. Proceeds were first allocated to liability instruments based on fair value, then allocated pro-rata to the equity instruments. Refer to Note 13 - *Warrants* for further information on the Series C Warrants.

***Series A Preferred Stock***

The shares of Series A Preferred Stock were issued pursuant to a Certificate of Designations (the "Series A Certificate of Designations") filed on September 13, 2024, as amended on September 17, 2024 (as described below), and rank senior to the Company's Common Stock with respect to the payment of dividends and distributions upon liquidation, dissolution or winding-up. Holders of the Series A Preferred Stock are entitled to receive dividend payments at a return equal to 8% per annum, payable in cash or in kind at the election of the Company. During the three and nine months ended September 30, 2025, the Company issued 4,003 shares of its Series A Preferred Stock for in kind payment of dividends on the instruments. As of September 30, 2025 and December 31, 2024, there were 100,000 shares of Series A Preferred Stock authorized, and there were 54,003 shares and 50,000 shares issued and outstanding, respectively.

Holders of the Series A Preferred Stock do not have voting rights. The Series A Preferred Stock is not convertible, nor are there any sinking-fund requirements. The Series A Preferred Stock is redeemable at the Company's option or mandatorily on September 13, 2027. The Company accounts for the Series A Preferred Stock as a liability in accordance with ASC 480, *Distinguishing Liabilities from Equity*. The Series A Preferred Stock is measured at the present value of the amount to be paid at settlement, accruing interest cost using the rate implicit at inception. As of September 30, 2025 and December 31, 2024, the Series A Preferred Stock liability was $26.3 million and $18.4 million, respectively. During the three and nine months ended September 30, 2025, the Company recognized $2.9 million and $7.8 million, respectively, of interest expense (which includes amortization of original issuance discount) on the Series A Preferred Stock. During the three and nine months ended September 30, 2024, the Company recognized $0.4 million of interest expense (which includes amortization of original issuance discount) on the Series A Preferred Stock.

The holders of the Series A Preferred Stock have a contingent put right (the "Put Option"), which was bifurcated and recognized separately at fair value through earnings pursuant to ASC 815-15, *Embedded Derivatives*. The Put Option is contingent upon the Company incurring any indebtedness after the initial issue date that is senior to the Series A Preferred Stock and/or secured by the assets of PureCycle Augusta, LLC. As of September 30, 2025, there was no fair value ascribed to the Put Option liability. As of December 31, 2024, the Put Option liability had a fair value of $3.4 million. During the three months ended September 30, 2025, there was no change to the Put Option liability. During the nine months ended September 30, 2025, the Company recognized income of $3.4 million related to the change in the Put Option fair value, which is recorded in other (income) expense, net in the

------

**PureCycle Technologies, Inc.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED**

**(Unaudited)**

Condensed Consolidated Statements of Comprehensive Loss. During the three and nine months ended September 30, 2024, the Company recognized expense of $0.4 million related to the change in the Put Option fair value. Refer to Note 14 - *Fair Value of Financial Instruments* for information related to the Put Option fair value.

The shares of Series A Preferred Stock will be redeemed in cash at a price equal to $1,050 per share (105% of the Initial Issue Price) regardless of whether they are called by the Company, put back to the Company by the holders, or redeemed on September 13, 2027. The Series A Preferred Stock is liability classified and presented within noncurrent liabilities, as preferred stock liability, and the put option liability is recorded within other noncurrent liabilities on the Condensed Consolidated Balance Sheets.

On September 17, 2024, the holders of all of the shares of Series A Preferred Stock entered into waivers to irrevocably and unconditionally waive (and consent to such waivers for purposes of Section 12 of the Series A Certificate of Designations) the rights of the holders of shares of Series A Preferred Stock, (i) pursuant to the Series A Certificate of Designations, (a) to elect to receive shares of the Company's Common Stock or pre-funded warrants to purchase the Company's Common Stock in connection with redemption events under the Series A Certificate of Designations, (b) to elect to receive additional shares of Series A Preferred Stock on return payment dates, and (c) to receive return payments on the first three quarterly return payment dates within each one-year period following the issue date and to instead receive such return payments on the fourth quarterly return payment date within each one-year period following the issue date, such that each holder of Series A Preferred Stock shall receive return payments for the entire one-year period preceding each such fourth quarterly return payment date, and (ii) pursuant to the Series A Subscription Agreements, to require the Company to register the shares of Common Stock issuable upon redemption of the Series A Preferred Stock on a registration statement filed by the Company.

Refer to Note 13 - *Warrants* for further information.

***Common Stock***

Holders of the Company's Common Stock are entitled to one vote for each share held of record on all matters submitted to a vote of stockholders. The holders do not have cumulative voting rights in the election of directors. Upon the Company's liquidation, dissolution or winding up and after payment in full of all amounts required to be paid to creditors and to the holders of preferred stock having liquidation preferences, if any, the holders of the Company's Common Stock will be entitled to receive pro rata the Company's remaining assets available for distribution. Holders of the Company's Common Stock do not have preemptive, subscription, redemption or conversion rights. All shares of the Company's Common Stock are fully paid and non-assessable. The Company is authorized to issue 450.0 million shares of Common Stock with a par value of $0.001. As of September 30, 2025 and December 31, 2024, 180.2 million and 173.6 million shares are issued and outstanding, respectively.

On February 5, 2025, the Company entered into subscription agreements with certain investors (the "Investors"), including affiliates of Sylebra, Pleiad Asia Master Fund, Pleiad Asia Equity Master Fund and affiliates of Samlyn, pursuant to which the Company agreed to sell to the Investors, in a private placement an aggregate of 4,091,293 shares of the Common Stock at a price of $8.0655 per share. Included in the Subscription Agreement were 524,349 shares of the Company's Common Stock sold to affiliates of Sylebra and Samlyn, both of whom are related parties due to their greater than 5% ownership interest in the Company, for approximately $4.2 million in proceeds before deducting fees and other estimated offering expenses. The transactions contemplated by the Subscription Agreements closed on February 6, 2025. The gross proceeds to the Company from the offering were approximately $33.0 million before deducting fees and other estimated offering expenses. As part of the Subscription Agreements, the Company filed a registration statement on March 4, 2025 registering the Common Stock sold in the offering on an existing shelf registration statement dated January 31, 2025.

------

**PureCycle Technologies, Inc.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED**

**(Unaudited)**

***Preferred Stock***

As of September 30, 2025 and December 31, 2024, the Company is authorized to issue 25.0 million shares of preferred stock with a par value of $0.001, of which 0.4 million shares and 0.1 million shares are issued and outstanding, respectively.

**NOTE 12 - EQUITY-BASED COMPENSATION**

***2021 Equity Incentive Plan***

On March 17, 2021, the Company's stockholders approved the PureCycle Technologies, Inc. 2021 Equity and Incentive Compensation Plan (the "Plan").

The Plan provides for the grant of stock options, stock appreciation rights, restricted stock awards, restricted stock units ("RSUs"), performance shares, performance units ("PSUs"), dividend equivalents, and certain other awards. In general, the amount of shares issuable under the Plan will be automatically increased on the first day of each fiscal year, beginning in 2022 and ending in 2031, by an amount equal to the lesser of (a) 3% of the shares of the Company's Common Stock outstanding on the last day of the immediately preceding fiscal year, or (b) such smaller number of shares as determined by the Board.

As of September 30, 2025, approximately 27.2 million shares of Common Stock are authorized for issuance under the Plan, of which approximately 17.7 million shares remain available for issuance under the Plan (assuming maximum performance with respect to the applicable performance goals related to the Plan awards issued).

***Restricted Stock Agreements***

RSUs issued pursuant to the Plan are time-based and vest over the period defined in each individual grant agreement or upon a change of control event as defined in the Plan. The Company recognizes compensation expense for the awards equal to the fair value on the date of grant of the awards on a straight-line basis over the vesting period of such awards. The grant-date fair value of the awards is equal to the closing price of the Company's Common Stock one day prior to the date of grant. The Company has the option to repurchase all vested shares upon a stockholder's termination of employment or service with the Company.

A summary of RSU activity for the nine months ended September 30, 2025 is as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **Number of RSUs<br>*(in thousands)*** | **Weighted Average Grant<br>Date Fair Value** | **Weighted Average Remaining Recognition<br>Period <br>*(in years)*** |
| **Non-vested at December 31, 2024** | **3438** | $**7.90** | 2.5 |
| &nbsp;&nbsp;&nbsp;Granted | 857 | 9.69 |  |
| &nbsp;&nbsp;&nbsp;Vested | (1137) | 9.04 |  |
| &nbsp;&nbsp;&nbsp;Forfeited | (125) | 6.72 |  |
| **Non-vested at September 30, 2025** | **3033** | $**8.02** | 2.5 |

---

------

**PureCycle Technologies, Inc.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED**

**(Unaudited)**

On December 31, 2024, the Company entered into an agreement with the Company's former Chief Financial Officer, whereby his restricted stock award set to expire on December 31, 2024 was extended an additional two years to December 31, 2026 in exchange for four quarterly payments of $0.2 million, beginning on December 31, 2024. The Company has received $0.2 million and $0.5 million during the three and nine months ended September 30, 2025, respectively, which has been recognized in additional paid-in capital within the Condensed Consolidated Balance Sheets.

On June 16, 2025, the Company and the Company's Chief Executive Officer entered into an employment agreement, pursuant to which he was entitled to receive a restricted stock award of 0.2 million shares of the Company's Common Stock that immediately vested. The total compensation cost associated with this award was $2.3 million and is recorded in selling, general and administrative expenses within the Condensed Consolidated Statements of Comprehensive Loss for the nine months ended September 30, 2025.

As of September 30, 2025, there were $15.9 million in compensation costs related to non-vested awards to be recognized over a weighted average remaining period of 2.5 years.

***Stock Options***

The stock options issued pursuant to the Plan are time-based and vest over the period defined in each individual grant agreement or upon a change of control event as defined in the Plan.

The Company recognizes compensation expense for the stock option awards based on the fair value at the date of grant on a straight-line basis over the vesting period of such awards. The fair value of the stock option award is calculated on the date of grant using the Black-Scholes option-pricing model based on the following assumptions:

---

| | | |
|:---|:---|:---|
|  | **For the Three and Nine Months Ended September 30,** | **For the Three and Nine Months Ended September 30,** |
|  | **2025** | **2024** |
| Expected annual dividend yield | 0.0% | 0.0% |
| Expected volatility | 89.9% - 90.2% | 88.5% |
| Risk-free rate of return | 4.06% - 4.45% | 4.3% |
| Expected option term (years) | 6.5 | 6.5 |

---

The expected term of the shares granted is determined based on the period of time the shares are expected to be outstanding. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant. The expected volatility is based on the Company's capital structure and volatility of similar entities referred to as guideline companies. In determining similar entities, the Company considered industry, stage of life cycle, size and financial leverage. The dividend yield on the Company's shares is assumed to be zero as the Company has not historically paid dividends on its Common Stock. The fair value of the underlying Company's Common Stock is determined using the closing stock price of the Company's Common Stock on the grant date.

------

**PureCycle Technologies, Inc.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED**

**(Unaudited)**

A summary of stock option activity for the nine months ended September 30, 2025 is as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **Number of Options<br>*(in thousands)*** | **Weighted Average Exercise Price** | **Weighted Average Remaining Contractual Term<br>*(in years)*** |
| **Balance, December 31, 2024** | **1290** | $**16.75** | 5.5 |
| &nbsp;&nbsp;&nbsp;Granted | 223 | 10.16 | 10.0 |
| &nbsp;&nbsp;&nbsp;Forfeited | (24) | 5.73 |  |
| **Balance, September 30, 2025** | **1489** | $**15.94** | 5.4 |
| Exercisable | 613 |  |  |
| **Weighted average grant date fair values** | $**10.16** |  |  |

---

As of September 30, 2025, there were $2.3 million in compensation costs related to non-vested awards to be recognized over a weighted average remaining period of 5.4 years.

***Performance-Based Restricted Stock Awards***

The shares issued pursuant to the Performance-Based Restricted Stock Agreements vest depending on if the performance obligations are met. In general, the PSUs will be earned based on achievement of pre-established financial and operational performance objectives and will vest on the date the attainment of such performance objectives as determined by the Compensation Committee of the Board, subject to the participant's continued employment with the Company. These grants allow for the right to receive a variable number of shares, between 0% and 200% of target.

The Company recognizes compensation expense for the PSUs equal to the grant-date fair value of the equity-based compensation awards on a straight-line basis over the vesting period of such awards as the Company has concluded the performance condition is probable to be met. The fair value of the awards is equal to the fair value of the Company's Common Stock one day prior to the date of grant.

A summary of the PSU activity for the nine months ended September 30, 2025 is as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **Number of PSUs<br>*(in thousands)*** | **Weighted Average Grant<br>Date Fair Value** | **Weighted Average Remaining Recognition Period<br>*(in years)*** |
| **Balance, December 31, 2024** | **1341** | $**6.82** | 1.7 |
| &nbsp;&nbsp;&nbsp;Granted | 194 | 10.15 |  |
| &nbsp;&nbsp;&nbsp;Vested | (2) | 6.60 |  |
| &nbsp;&nbsp;&nbsp;Forfeited | (598) | 7.63 |  |
| **Balance, September 30, 2025** | **935** | $**6.99** | 1.8 |

---

As of September 30, 2025, there were $3.0 million in compensation costs related to non-vested awards to be recognized over a weighted average remaining period of 1.8 years.

------

**PureCycle Technologies, Inc.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED**

**(Unaudited)**

Equity-based compensation cost is recorded within the cost of operations and selling, general and administrative expenses within the Condensed Consolidated Statements of Comprehensive Loss. Equity-based compensation expense for the three and nine months ended September 30, 2025 and 2024 is presented in the following table:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| ***(in thousands)*** | **2025** | **2024** | **2025** | **2024** |
| Total equity-based compensation for RSUs | $2300 | $2845 | $8604 | $8059 |
| Total equity-based compensation for Restricted stock award |  |  | 2268 |  |
| Total equity-based compensation for stock options | 379 | 211 | 1006 | 624 |
| Total equity-based compensation for PSUs | 224 | (97) | 790 | 30 |
| &nbsp;&nbsp;&nbsp;Total equity-based stock compensation expense | $2903 | $2959 | $12668 | $8713 |

---

**NOTE 13 - WARRANTS**

The Company has the following series of warrants outstanding (in thousands, except per-share values) as of September 30, 2025 and December 31, 2024, all of which are exercisable:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Warrant series** | **September 30, 2025** | **December 31, 2024** | **Exercise price** | **Expiration date** |
| RTI Global ("RTI") Warrants |  | 1511 | $5.56 | January 17, 2025 |
| Public Warrants | 5715 | 5720 | $11.50 | March 17, 2026 |
| Private Warrants | 199 | 199 | $11.50 | March 17, 2026 |
| Series A Warrants | 17757 | 17857 | $11.50 | March 17, 2026 |
| Series B Warrants | 3064 | 3064 | $11.50 | December 1, 2030 |
| Series C Warrants | 5000 | 5000 | $11.50 | December 1, 2030 |
| &nbsp;&nbsp;Total warrants, issued and outstanding | 31735 | 33351 |  |  |

---

***RTI Warrants***

On January 16, 2025, RTI exercised their outstanding warrants (the "RTI Warrants"). The Company received $5.4 million in cash and issued 1.5 million shares of Common Stock to RTI.

***Public Warrants and Private Warrants***

The Company has outstanding public and private warrants that entitle each holder to exercise its warrants for a whole number of shares of the Company's Common Stock at a price of $11.50 per share. The warrants expire March 17, 2026, or earlier upon redemption or liquidation. The private warrants are identical to the public warrants, except that the private warrants are non-redeemable so long as they are held by the initial holder or any of its permitted transferees. If the private warrants are held by someone other than the initial holder or its permitted transferees, the private warrants will be redeemable by the Company and exercisable by such holders on the same basis as the public warrants.

The Company may redeem the outstanding warrants in whole, but not in part, at a price of $0.01 per warrant upon a minimum of 30 days' prior written notice of redemption, if and only if the last sale price of the Company's Common Stock equals or exceeds $18.00 per share for any 20 trading days within a 30-day trading period ending three business days before the Company sends the notice of redemption to the warrant holders. If the Company calls the warrants for redemption, management will have the option to require all holders that wish to exercise the warrants to do so on a cashless basis. In no event will the Company be required to net cash settle the warrant exercise.

------

**PureCycle Technologies, Inc.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED**

**(Unaudited)**

The public warrants are accounted for as equity-classified warrants as they were determined to be indexed to the Company's stock and meet the requirements for equity classification. The private warrants are accounted for as liability-classified as there is a provision within the warrant agreement that allows for private warrants to be exercised via a cashless exercise while held by the holder and affiliates of the original holder, but would not be exercisable at any time on a cashless basis if transferred and held by another investor. Therefore, the Company classifies the private warrants as a liability pursuant to ASC 815, *Derivatives and Hedging Activities*, until the private warrants are transferred from the initial purchasers or any of their permitted transferees. As of September 30, 2025, approximately 136,000 of the private warrants have been transferred from the initial purchasers.

During the three and nine months ended September 30, 2025, 5,756 public warrants were exercised by warrant holders. The Company received $0.1 million in cash and issued 5,576 shares of Common Stock.

Refer to Note 14 - *Fair Value of Financial Instruments* for further information.

***Series A Warrants***

On March 7, 2022, the Company issued approximately 17.9 million Series A Warrants to certain investors in connection with a private placement in 2022 to purchase shares of the Company's Common Stock. Each whole warrant entitles the registered holder to purchase one whole share of the Company's Common Stock at a price of $11.50 per share any time after September 17, 2022. The warrants expire on March 17, 2026.

On April 11, 2025, the Company entered into a side letter agreement with certain holders of the Series A Warrants to forbear the Company's exercise of its redemption rights with respect to those certain holders' Series A Warrants. As a consequence of such side letter, the Company is unable to redeem the Series A Warrants for *any* holder of the Series A Warrants prior to the expiration of the Series A Warrants.

The agreements governing the Series A Warrants provide for a Black-Scholes value calculation in the event of certain transactions, which includes a floor on volatility utilized in the value calculation at 100% or greater. The Company has determined this provision introduces leverage to the holders of the Series A Warrants that could result in a value that would be greater than the settlement amount of a fixed-for-fixed option on the Company's own equity shares. Therefore, the Company has classified the Series A Warrants as a liability pursuant to ASC 815, *Derivatives and Hedging Activities*.

On July 28, 2025, Glockner, a related party of the Company, exercised 0.1 million of their outstanding Series A Warrants. The Company received $1.2 million in cash and issued 0.1 million shares of Common Stock to Glockner.

Refer to Note 14 - *Fair Value of Financial Instruments* for further information.

***Series B Warrants***

On May 10, 2024, the Company issued Series B Warrants to Pure Plastic to purchase an aggregate of 3.1 million shares of the Company's Common Stock (the "Series B Warrant Agreement"). Each whole warrant entitles the registered holder to purchase one whole share of the Company's Common Stock at a price of $11.50 per share. The Series B Warrants expire on December 1, 2030, but may be subject to redemption at any time after January 1, 2028, if certain Common Stock price thresholds are met.

The Series B Warrant Agreement provides for a Black-Scholes value calculation in the event of certain transactions, which includes a floor on volatility utilized in the value calculation at 100% or greater. The Company has determined this provision introduces leverage to the holders of the Series B Warrants that could result in a value that would be greater than the settlement amount of a fixed-for-fixed option on the Company's own equity shares. Therefore, the Company classified the Series B Warrants as a liability pursuant to ASC 815, *Derivatives and Hedging Activities*.

------

**PureCycle Technologies, Inc.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED**

**(Unaudited)**

Refer to Note 14 - *Fair Value of Financial Instruments* for further information.

***Series C Warrants***

On September 13, 2024, pursuant to the Series A Subscription Agreements, the Company issued Series C Warrants to purchase an aggregate of 5.0 million shares of the Company's Common Stock. Each warrant is exercisable at a price per share of the Company's Common Stock of $11.50, subject to adjustment for splits, dividends, recapitalizations and other similar events. The Series C Warrants expire on December 1, 2030, but may be subject to redemption at any time after January 1, 2029, if certain Common Stock price thresholds are met.

The Series C Warrant Agreement provides for a Black-Scholes value calculation in the event of certain transactions, which includes a floor on volatility utilized in the value calculation at 100% or greater. The Company has determined this provision introduces leverage to the holders of the Series C Warrants that could result in a value that would be greater than the settlement amount of a fixed-for-fixed option on the Company's own equity shares. Therefore, the Company has classified the Series C Warrants as a liability pursuant to ASC 815, *Derivatives and Hedging Activities*.

Refer to Note 14 - *Fair Value of Financial Instruments* for further information.

Warrant (benefit)/expense recognized during the three and nine months ended September 30, 2025 and 2024 is presented in the following table:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| ***(in thousands)*** | **2025** | **2024** | **2025** | **2024** |
| RTI Warrants | $— | $7274 | $(1291) | $7614 |
| Private Warrants | (69) | 319 | 6 | 407 |
| Series A Warrants | (17124) | 25352 | (774) | 33209 |
| Series B Warrants | (2452) | 9254 | 490 | 10602 |
| Series C Warrants | (4100) | 2700 | 3450 | 2700 |
| &nbsp;&nbsp;&nbsp;Change in fair value of warrants | $(23745) | $44899 | $1881 | $54532 |

---

**NOTE 14 – FAIR VALUE OF FINANCIAL INSTRUMENTS** 

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date and sets out a fair value hierarchy. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). Inputs are broadly defined as assumptions market participants would use in pricing an asset or liability. Assets and liabilities carried at fair value are classified and disclosed in one of the following three categories:

*Level 1* - Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.

*Level 2* - Inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly, and fair value is determined through the use of models or other valuation methodologies.

*Level 3* - Inputs are unobservable for the asset or liability and include situations where there is little, if any, market activity for the asset or liability. The inputs into the determination of fair value are based upon the best information in the circumstances and may require significant management judgment or estimation.

------

**PureCycle Technologies, Inc.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED**

**(Unaudited)**

The Company records cash and cash equivalents, restricted cash, accounts receivable and accounts payable at cost, which approximates fair value due to their short-term nature or stated rates. The Company records debt at cost less any discounts and issuance costs.

***Financial Instruments Measured and Recorded at Fair Value on a Recurring Basis***

As of September 30, 2025 and December 31, 2024, the Company's financial liabilities measured and recorded at fair value on a recurring basis were classified within the fair value hierarchy as follows:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| ***(in thousands)*** | **Level 1** | **Level 2** | **Level 3** | **Total** | **Level 1** | **Level 2** | **Level 3** | **Total** |
| *Liabilities* |  |  |  |  |  |  |  |  |
| **Put Option Liability** | $— | $— | $— | $— | $— | $— | $3443 | $3443 |
| **Warrant liability:** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;RTI Warrants |  |  |  |  |  |  | 10109 | 10109 |
| &nbsp;&nbsp;&nbsp;Private Warrants - liability classified |  |  | 216 | 216 |  |  | 443 | 443 |
| &nbsp;&nbsp;&nbsp;Series A Warrants |  | 60019 |  | 60019 |  | 61329 |  | 61329 |
| &nbsp;&nbsp;&nbsp;Series B Warrants |  |  | 20958 | 20958 |  |  | 20468 | 20468 |
| &nbsp;&nbsp;&nbsp;Series C Warrants |  |  | 41300 | 41300 |  |  | 37850 | 37850 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total warrant liability | $— | $60019 | $62474 | $122493 | $— | $61329 | $68870 | $130199 |

---

As of September 30, 2025 and December 31, 2024, the estimated fair value of the Company's financial instruments not remeasured at fair value on a recurring basis within the fair value hierarchy are as follows:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| ***(in thousands)*** | **Level 1** | **Level 2** | **Level 3** | **Total** | **Level 1** | **Level 2** | **Level 3** | **Total** |
| **Green Convertible Notes** | $— | $— | $298135 | $298135 | $— | $— | $233125 | $233125 |
| **Revenue bonds** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Related party bonds |  |  | 115259 | 115259 |  |  | 98481 | 98481 |
| &nbsp;&nbsp;&nbsp;Third-party bonds |  |  | 30184 | 30184 |  |  | 11044 | 11044 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenue bonds | $— | $— | $145443 | $145443 | $— | $— | $109525 | $109525 |

---

For the instruments classified as Level 3, significant changes in any of the significant unobservable inputs in isolation would not result in a materially different fair value estimate. The fair value of the liabilities above is derived from the trading price of the Company's publicly traded bonds on the last trading day of the fiscal quarter. The Company's publicly traded bonds are thinly traded and, as such, the Company has deemed the input as an unobservable input. Since each of the instruments classified as Level 3 are being valued using similar inputs, a significant change that would impact expected volatility or the market price of PCT's Common Stock could result in a material change to the total combined value of these instruments. An increase in one or both of these inputs would result in a higher assessed value for each instrument.

**Measurement of the Private Warrants**

The private warrants are measured at fair value on a recurring basis using a Black-Scholes model. The private warrants are classified as Level 3 and were valued using the following assumptions:

---

| | | |
|:---|:---|:---|
|  | **September 30, 2025** | **December 31, 2024** |
| Expected annual dividend yield | —% | —% |
| Expected volatility | 72.1% | 93.1% |
| Risk-free rate of return | 3.8% | 4.1% |
| Expected option term (years) | 0.5 | 1.2 |

---

------

**PureCycle Technologies, Inc.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED**

**(Unaudited)**

The expected term of the private warrants is determined based on the duration of time the warrants are expected to be outstanding. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of issuance. The expected volatility is based on the implied volatility calculated for the Company's public warrants, which have similar characteristics to the private warrants. The dividend yield on the Company's private warrants is assumed to be zero as the Company has not historically paid dividends on its Common Stock. The fair value of the underlying Company shares was determined using a Black-Scholes value calculation.

A summary of the private warrants activity from December 31, 2024 to September 30, 2025 is as follows:

---

| | |
|:---|:---|
| ***(in thousands)*** | **Fair Value<br>(Level 3)** |
| **Balance, December 31, 2024** | $**443** |
| &nbsp;&nbsp;&nbsp;Warrants transferred from initial purchaser | (233) |
| &nbsp;&nbsp;&nbsp;Change in fair value | 6 |
| **Balance, September 30, 2025** | $**216** |

---

Refer to Note 13 - *Warrants* for further information.

**Measurement of the RTI Warrants**

On January 16, 2025, RTI exercised its outstanding warrants. The Company received $5.4 million in cash and issued 1.5 million shares of the Company's Common Stock. The Company determined the RTI Warrants were to be measured using a Level 3 fair value measurement and was remeasured using a Binomial Tree option pricing model to calculate its fair value using the following assumptions:

---

| | |
|:---|:---|
|  | **December 31, 2024** |
| Expected annual dividend yield | —% |
| Expected volatility | 77.1% |
| Risk-free rate of return | 4.4% |
| Expected option term (years) | 0.1 |

---

The expected term of the RTI Warrants was determined based on the duration of time the warrants were expected to be outstanding. The risk-free rate was based on the U.S. Treasury yield curve in effect at the time of grant. The expected volatility was calculated based on the specific volatility of PCT's publicly-traded Common Stock. The dividend yield on the Company's warrants was assumed to be zero as the Company has not historically paid dividends on its Common Stock. The fair value of the underlying Company shares was determined using a Binomial Tree pricing model.

A summary of the RTI Warrants activity from December 31, 2024 to September 30, 2025 is as follows:

---

| | |
|:---|:---|
| ***(in thousands)*** | **Fair Value<br>(Level 3)** |
| **Balance, December 31, 2024** | $**10109** |
| &nbsp;&nbsp;&nbsp;Change in fair value | (1291) |
| &nbsp;&nbsp;&nbsp;Exercise of warrants | (8818) |
| **Balance, September 30, 2025** | $**—** |

---

------

**PureCycle Technologies, Inc.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED**

**(Unaudited)**

***Measurement of the Series A Warrants***

The Series A Warrants meet the definition of derivative instruments and are measured at fair value on a recurring basis using the market price of the Company's publicly traded warrants, with changes in fair value recorded in current earnings. The Company has determined the publicly traded warrants to be an appropriate proxy to value the Series A Warrants as both warrants have similar redemption features and the same exercise price. The Series A Warrants are classified as Level 2 for both initial measurement at issuance and subsequent measurement each period.

***Measurement of the Series B Warrants***

The Series B Warrants meet the definition of derivative instruments and are measured at fair value on a recurring basis. The Company has determined the Series B Warrants to be a Level 3 fair value measurement and has performed initial recognition and ongoing remeasurement using a Monte Carlo simulation to calculate its fair value using the following assumptions:

---

| | | |
|:---|:---|:---|
|  | **September 30, 2025** | **December 31, 2024** |
| Expected annual dividend yield | —% | —% |
| Expected volatility | 72.1% | 93.1% |
| Risk-free rate of return | 3.7% | 4.4% |
| Expected option term (years) | 5.2 | 5.9 |

---

The expected term of the Series B Warrants is determined based on the duration of time the warrants are expected to be outstanding. The risk-free rate is based on the U.S. Treasury yield curve in effect at the valuation date. The expected volatility is based on the implied volatility calculated for the Company's public warrants, which have similar characteristics to the Series B Warrants. The dividend yield on the Company's warrants is assumed to be zero as the Company has not historically paid dividends on its Common Stock. The fair value of the underlying Company shares was determined using a Monte Carlo simulation.

A summary of the Series B Warrants activity from December 31, 2024 to September 30, 2025 are as follows:

---

| | |
|:---|:---|
| ***(in thousands)*** | **Fair Value<br>(Level 3)** |
| **Balance, December 31, 2024** | $**20468** |
| &nbsp;&nbsp;&nbsp;Change in fair value | 490 |
| **Balance, September 30, 2025** | $**20958** |

---

***Measurement of the Series C Warrants***

The Series C Warrants meet the definition of derivative instruments and are measured at fair value on a recurring basis. The Company has determined the Series C Warrants to be a Level 3 fair value measurement and has performed initial recognition and ongoing remeasurement using a Monte Carlo simulation to calculate its fair value using the following assumptions:

---

| | | |
|:---|:---|:---|
|  | **September 30, 2025** | **December 31, 2024** |
| Expected annual dividend yield | —% | —% |
| Expected volatility | 72.1% | 93.1% |
| Risk-free rate of return | 3.7% | 4.4% |
| Expected option term (years) | 5.2 | 5.9 |

---

------

**PureCycle Technologies, Inc.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED**

**(Unaudited)**

The expected term of the Series C Warrants granted is determined based on the duration of time the warrants are expected to be outstanding. The risk-free rate is based on the U.S. Treasury yield curve in effect at the valuation date. The expected volatility is based on the implied volatility calculated for the Company's public warrants, which have similar characteristics to the Series B Warrants. The dividend yield on the Company's warrants is assumed to be zero as the Company has not historically paid dividends on its Common Stock. The fair value of the underlying Company shares was determined using a Monte Carlo simulation.

A summary of the Series C Warrants activity from December 31, 2024 to September 30, 2025 are as follows:

---

| | |
|:---|:---|
| ***(in thousands)*** | **Fair Value<br>(Level 3)** |
| **Balance, December 31, 2024** | $**37850** |
| &nbsp;&nbsp;&nbsp;Change in fair value | 3450 |
| **Balance, September 30, 2025** | $**41300** |

---

***Measurement of the Put Option Liability***

The Put Option liability meets the definition of a derivative instrument and is measured at fair value on a recurring basis. The Company has determined the Put Option liability to be a Level 3 fair value measurement and has performed initial recognition and ongoing remeasurement using a Monte Carlo simulation to calculate its fair value using the following assumptions:

---

| | | |
|:---|:---|:---|
|  | **September 30, <br>2025** <sup>(1)</sup> | **December 31, 2024** |
| Risk-free rate of return | —% | 4.4% |
| Credit spread | —% | 16.7% |

---

__________

<sup>(1)</sup> During June 2025, the Company announced its plans to construct a new polypropylene recycling facility in Thailand, which has adjusted the timeline on construction of the Augusta Facility. Because the Put Option is contingent upon the Company incurring any indebtedness that is senior to the Series A Preferred Stock and/or secured by the assets of PureCycle Augusta, LLC, this adjusted timeline has resulted in the likelihood of the Put Option being exercised as remote. Accordingly, there has been no value ascribed to the Put Option as of September 30, 2025.

A summary of the Put Option activity from December 31, 2024 to September 30, 2025 are as follows:

---

| | |
|:---|:---|
| ***(in thousands)*** | **Fair Value<br>(Level 3)** |
| **Balance, December 31, 2024** | $**3443** |
| &nbsp;&nbsp;&nbsp;Change in fair value | (3443) |
| **Balance, September 30, 2025** | $**—** |

---

In determining the appropriate levels, the Company performs a detailed analysis of the assets and liabilities that are subject to fair value measurements.

------

**PureCycle Technologies, Inc.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED**

**(Unaudited)**

**NOTE 15 – NET LOSS PER SHARE**

The Company follows the two-class method when computing net loss per common share when shares are issued that meet the definition of participating securities. The two-class method requires income available to common stockholders for the period to be allocated between common and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. The two-class method also requires losses for the period to be allocated between common and participating securities based on their respective rights if the participating security contractually participates in losses. As holders of participating securities do not have a contractual obligation to fund losses, undistributed net losses are not allocated to nonvested restricted stock for purposes of the loss per share calculation.

The dilutive effect for the Company's Green Convertible Notes and Series B Convertible Perpetual Preferred stock is calculated using the "if-converted" method. The dilutive effect of all other instruments is calculated using the treasury stock method.

The computation for the basic and diluted loss per share for the three and nine months ended September 30, 2025 and 2024 are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| ***(in thousands, except per share data)*** | **2025** | **2024** | **2025** | **2024** |
| **Numerator:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Net loss | $(28370) | $(90639) | $(163778) | $(224458) |
| &nbsp;&nbsp;&nbsp;Less: Dividends accumulated on Series B Convertible <br> Perpetual Preferred Stock | 5344 |  | 5927 |  |
| &nbsp;&nbsp;&nbsp;**Basic net loss attributable to common <br> stockholders** | **(33714)** | **(90639)** | **(169705)** | **(224458)** |
| &nbsp;&nbsp;&nbsp;*Less: Dilutive impact of -* |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Private Warrants | 69 |  | 69 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Series A Warrants | 17224 |  | 17224 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Series B Warrants | 2452 |  | 2452 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Series C Warrants | 4100 |  | 4100 |  |
| &nbsp;&nbsp;&nbsp;**Diluted net loss attributable to common <br> stockholders** | $**(57559)** | $**(90639)** | $**(193550)** | $**(224458)** |
| **Denominator:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;**Weighted average common shares outstanding, <br> basic** | **180069** | **166513** | **179024** | **165224** |
| &nbsp;&nbsp;&nbsp;*Dilutive shares:* |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Private Warrants | 34 |  | 11 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Series A Warrants | 3059 |  | 1020 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Series B Warrants | 528 |  | 176 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Series C Warrants | 861 |  | 287 |  |
| &nbsp;&nbsp;&nbsp;**Weighted average common shares outstanding, <br> dilutive** | **184551** | **166513** | **180518** | **165224** |
| **Net loss per share attributable to common <br> stockholders, basic** | $**(0.19)** | $**(0.54)** | $**(0.95)** | $**(1.36)** |
| **Net loss per share attributable to common <br> stockholders, diluted** | $**(0.31)** | $**(0.54)** | $**(1.07)** | $**(1.36)** |

---

------

**PureCycle Technologies, Inc.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED**

**(Unaudited)**

Certain outstanding Common Stock equivalents were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented as including them would have been anti-dilutive. A summary of those outstanding Common Stock equivalents is presented in the following table:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| ***(in thousands)*** | **2025** | **2024** | **2025** | **2024** |
| **Anti-dilutive shares** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Warrants | 5715 | 33351 | 5715 | 33351 |
| &nbsp;&nbsp;&nbsp;Stock options | 1505 | 1289 | 1505 | 1289 |
| &nbsp;&nbsp;&nbsp;RSUs | 3033 | 3569 | 3033 | 3569 |
| &nbsp;&nbsp;&nbsp;PSUs | 937 | 1371 | 937 | 1371 |
| &nbsp;&nbsp;&nbsp;Contingently - issuable shares to Legacy PCT unitholders <sup>(1)</sup> | 2000 | 2000 | 2000 | 2000 |
| &nbsp;&nbsp;&nbsp;Shares issuable upon conversion of Green Convertible Notes | 16869 | 16869 | 16869 | 16869 |
| &nbsp;&nbsp;&nbsp;Shares issuable upon conversion of Series B Convertible Perpetual Preferred Stock | 21821 |  | 21821 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total anti-dilutive shares | 51880 | 58449 | 51880 | 58449 |

---

<sup>__________</sup>

<sup>(1)</sup> In connection with the initial business combination and merger agreement as described in the Company's Annual Report on Form 10-K for the year ended December 31, 2024, legacy PCT unitholders will be entitled to 2.0 million shares upon the Ironton Facility becoming operational, as certified by Leidos Engineering, LLC, an independent engineering firm, in accordance with criteria established in agreements in connection with construction of the plant.

**NOTE 16 - SUBSEQUENT EVENTS**

During October 2025, the Company paid off the entire outstanding balance of the CSC Equipment Financing Payable and recorded a loss on extinguishment of approximately $4.4 million.

On November 4, 2025, the Company entered into the Tenth Amendment to the Revolving Credit Agreement, which extended the maturity date of the Revolving Credit Facility from September 30, 2026 to September 30, 2027 and added a clause regarding the potential redemption of Series A Preferred Stock. If, on or prior to March 17, 2026, sufficient proceeds are received from the exercise of Series A Warrants and the Board of Directors approve, then the Company shall redeem in full the Series A Preferred Stock.

------

**PureCycle Technologies, Inc.**

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations**

**CAUTIONARY STATEMENT ON FORWARD-LOOKING STATEMENTS**

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including statements about the financial condition, results of operations, earnings outlook and prospects of PureCycle Technologies, Inc. ("PCT"). Forward-looking statements generally relate to future events or PCT's future financial or operating performance and may refer to projections and forecasts. Forward-looking statements are typically identified by words such as "plan," "believe," "expect," "anticipate," "intend," "outlook," "estimate," "forecast," "project," "continue," "could," "may," "might," "possible," "potential," "predict," "should," "would" and other similar words and expressions (or the negative versions of such words or expressions), but the absence of these words does not mean that a statement is not forward-looking.

The forward-looking statements are based on the current expectations of the management of PCT and are inherently subject to uncertainties and changes in circumstances and their potential effects and speak only as of the date of this Quarterly Report on Form 10-Q. There can be no assurance that future developments will be those that have been anticipated. These forward-looking statements involve a number of risks, uncertainties or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described in the section of PCT's Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the "Annual Report on Form 10-K") entitled "Risk Factors," those discussed and identified in other public filings made with the U.S. Securities and Exchange Commission (the "SEC") by PCT and the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•PCT's ability to obtain funding for its operations and future growth and to continue as a going concern;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•PCT's ability to meet, and to continue to meet, applicable regulatory requirements for the use of PCT's PureFive™ resin in food grade applications (including in the United States, Europe, Asia and other future international locations);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•PCT's ability to comply on an ongoing basis with the numerous regulatory requirements applicable to the PureFive™ resin and PCT's facilities (including in the United States, Europe, Asia and other future international locations);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•expectations and changes regarding PCT's strategies and future financial performance, including its future business plans, expansion plans or objectives, prospective performance and opportunities and competitors, revenues, products and services, pricing, operating expenses, market trends, liquidity, cash flows and uses of cash, capital expenditures, and PCT's ability to invest in growth initiatives, which could be impacted by significant changes to tariffs on foreign imports;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•the ability of PCT's first commercial-scale recycling facility in Lawrence County, Ohio (the "Ironton Facility") to be appropriately certified by Leidos, following certain performance and other tests, and commence full-scale commercial operations in a timely and cost-effective manner, or at all;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•PCT's ability to meet, and to continue to meet, the requirements imposed upon it and its subsidiaries by the funding for its operations, including the funding for the Ironton Facility;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•PCT's ability to minimize or eliminate the many hazards and operational risks at its manufacturing facilities that can result in potential injury to individuals, disrupt its business (including interruptions or disruptions in operations at its facilities), and subject PCT to liability and increased costs;

------

**PureCycle Technologies, Inc.**

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations — CONTINUED**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•PCT's ability to complete the necessary funding with respect to, and complete the construction of its new polypropylene recycling facility in Thailand, its first commercial-scale European plant located in Antwerp, Belgium, and the multi-line purification facility to be built in Augusta, Georgia (the "Augusta Facility") in a timely and cost-effective manner;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•PCT's ability to execute its growth plan to bring an additional one billion pounds of installed polypropylene recycling capability online before 2030, including its ability to meet related construction, regulatory, and financing requirements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•PCT's ability to procure, sort and process polypropylene plastic waste at its planned plastic waste prep ("Feed PreP") facilities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•PCT's ability to maintain exclusivity under The Procter & Gamble Company ("P&G") license (as described below);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•the implementation, market acceptance and success of PCT's business model and growth strategy;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•the success or profitability of PCT's offtake arrangements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•the potential impact of economic, business, and/or competitive factors, including interest rates, availability of capital, economic cycles, and other macro-economic impacts (such as tariffs);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•changes in the prices and availability of materials (such as steel and other materials needed for the construction of future PreP and purification facilities), including those changes caused by inflation, tariffs and supply chain conditions, such as increased transportation costs, and our ability to obtain such materials in a timely and cost-effective manner;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•the ability to source feedstock with a high polypropylene content at a reasonable cost;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•PCT's future capital requirements and sources and uses of cash;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•developments and projections relating to PCT's competitors and industry;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•the outcome of any legal or regulatory proceedings to which PCT is, or may become, a party;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•geopolitical risk and changes in applicable laws or regulations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•the possibility that PCT may be adversely affected by other economic, business, and/or competitive factors, including interest rates, availability of capital, economic cycles, and other macro-economic impacts;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•turnover in employees and increases in employee-related costs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•changes in the prices and availability of labor (including labor shortages);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•any business disruptions due to political or economic instability, pandemics, or armed hostilities (including the ongoing conflict between Russia and Ukraine and the conflict in the Middle East);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•the potential impact of climate change on PCT, including physical and transition risks, higher regulatory and compliance costs, reputational risks, and availability of capital on attractive terms; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•operational risk.

PCT undertakes no obligation to update any forward-looking statements made in this Quarterly Report on Form 10-Q to reflect events or circumstances after the date of this Quarterly Report on Form 10-Q or to reflect new information or the occurrence of unanticipated events, except as required by law.

------

**PureCycle Technologies, Inc.**

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations — CONTINUED**

Should one or more of these risks or uncertainties materialize or should any of the assumptions made prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. You should not rely upon forward-looking statements as predictions of future events.

------

**PureCycle Technologies, Inc.**

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations — CONTINUED**

*The following discussion and analysis provides information that PCT's management believes is relevant to an assessment and understanding of PCT's interim condensed consolidated results of operations and financial condition. The discussion should be read together with the audited consolidated financial statements and the accompanying notes and Management's Discussion and Analysis of Financial Condition and Results of Operations included in our most recent Annual Report on Form 10-K, as well as the unaudited interim condensed consolidated financial statements, together with related notes thereto, included elsewhere in this Quarterly Report on Form 10-Q. Unless the context otherwise requires, references in this "Management's Discussion and Analysis of Financial Condition and Results of Operations" to "we," "us," and "our," are intended to mean the business and operations of PCT and its consolidated subsidiaries.*

**Overview**

We are a Florida-based corporation focused on commercializing a patented dissolution recycling technology to physically separate the polymer from other plastics, color, and contaminants (the "Technology"), originally developed by P&G, for restoring waste polypropylene into resin, called PureFive™ resin, which has similar properties and applicability for reuse as virgin polypropylene. PCT has a global license for the Technology from P&G, which was amended during 2025 to permanently waive the possible clawback of our exclusivity for plants located in North America and extend the time in which our plants must begin construction and commence sales in other regions to avoid a clawback of exclusivity under the license agreement. In April 2023, we certified the Ironton Facility as mechanically complete. We expect to have capacity of approximately 107 million pounds per year when fully operational. Commissioning activities are ongoing, but the plant is not yet operating at the expected full capacity. Our goal is to create an important new segment of the global polypropylene market that will assist multinational entities in meeting their sustainability goals, providing consumers with polypropylene-based products that are sustainable, and reducing overall polypropylene waste in the world's landfills and oceans.

PCT's process includes the following steps:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Feed PreP collects, sorts, and prepares polypropylene waste ("feedstock") for purification.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Purification is a dissolution recycling process that uses a combination of solvent, temperature, and pressure to return the feedstock to near-virgin condition through a novel configuration of commercially-available equipment and unit operations. The purification process puts the plastic through a physical extraction process using supercritical fluids that both extract and filter out other plastics and additives to purify the color, opacity, and odor of the plastic without changing the bonds of the polymer. By not altering the chemical makeup of the polymer, we are able to use significantly less energy and reduce production costs as compared to virgin resin.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Compounding, which involves blending our resin with either virgin resin or additives, is a step that can be used on a case-by-case basis. Compounding allows for the modification of the resin to meet the end-user's qualifications with melt flow, flexibility, clarity and strength being some of the properties that can be tailored through compounding.

------

**PureCycle Technologies, Inc.**

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations — CONTINUED**

**Recent Developments**

In June 2025, we entered into binding subscription agreements with certain investors, including related parties, to which we agreed to sell to the investors, in a private placement transaction, an aggregate of 300,000 shares of the Company's Series B Convertible Perpetual Preferred Stock, par value $0.001 per share (the "Series B Convertible Perpetual Preferred Stock"), at an initial issue price of $1,000 per share. The gross proceeds from the offering were approximately $300.0 million before deducting fees and expenses.

In conjunction with the $300.0 million capital raise, we outlined our future growth plans to increase our installed capacity, which includes the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•We announced that we will begin construction of a 130.0 million pound polypropylene recycling facility in Thailand. We will be working with IRPC Public Company Limited ("IRPC") at IRPC's eco-industrial zone in Rayong, Thailand. IRPC is an integrated petrochemical operator in Southeast Asia. Its production structure comprises petroleum and petrochemical complexes, complete with utilities and infrastructure supporting the operations, including a deep-sea port, oil depots and power plants. We intend to leverage this existing site infrastructure to reduce the costs of certain construction activities. The permitting process has begun for this site, and the facility is expected to become operational in 2027.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•We also plan to construct a 130.0 million pound polypropylene recycling facility at our Antwerp, Belgium site. We are currently advancing the permitting process in Belgium and expect to submit all permits by the end of 2025. The facility in Antwerp is projected to be operational in 2028.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•We also plan to build a 300.0 million pound multi-line purification facility at our Augusta, Georgia location. The design of the larger purification facility will incorporate learnings from our Ironton Facility. This line is planned to be integrated with pre-processing ("PreP") and compounding assets. We expect to have the first purification line at the Augusta Facility operational in 2029.

***Letter of No Objection Submission ("LNO") and the Granting of Food and Drug Administration ("FDA") Food Packaging Clearances for Certain Feedstocks***

Our FDA food contact grade resins are, subject to certain conditions, capable of being used for all food types per the conditions of use listed and per all applicable authorizations in the food contact regulations listed in the 21 CFR (*Code of Federal Regulations, Title 21*).

During 2025, we received additional FDA LNOs, which expand upon previous LNOs and allows our PureFive™ resin to be produced under a broader range of process conditions. These broader conditions allow for greater flexibility and reduced energy usage in the purification process. Subject to operating under these process conditions, our resin can be used in articles in contact with all types of food under FDA's Conditions of Use ("COU") "A" ("high temperature heat-sterilized") through "H" ("frozen or refrigerated storage: ready-prepared foods intended to be reheated in containers at time of use"), provided the feedstock comes from food contact articles and complies with all applicable authorizations.

We are conducting additional testing and plan to make further LNO submissions for additional post-consumer recycled feedstock sources and expanded COUs.

------

**PureCycle Technologies, Inc.**

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations — CONTINUED**

**Components of Results of Operations**

***Revenue***

Our revenue is primarily generated from the sale of finished products or byproducts to customers. Those sales predominantly contain a single performance obligation and revenue is recognized at the point in time when control of the product is transferred to customers, along with the title, risk of loss and rewards of ownership. Depending on the arrangement with the customer, these criteria are met either at the time the product is shipped or when the product is made available or delivered to the destination specified in the agreement with the customer. Net sales revenue is recognized on the net amount expected to be received by the Company from the customer.

***Cost of Operations***

Operating expenses to date have consisted mainly of personnel costs (including wages, salaries and benefits) and other costs directly related to operations at our operating facilities, including feedstock, rent, depreciation, repairs and maintenance, utilities and supplies. Costs attributable to the design and development of Feed PreP and purification facilities are capitalized and, when placed in service, depreciated over the expected useful life of the asset. We expect our operating costs to increase as we continue to scale operations and increase headcount.

***Research and Development Expense***

Research and development expenses consist primarily of costs related to the development of the Technology, the facilities and equipment that will use the Technology to purify recycled polypropylene, and the processes needed to collect, sort, and prepare feedstock for purification. These include mainly personnel costs, depreciation for long-lived assets, third-party consulting costs, and the cost of various recycled waste. Research and development expenses include evaluation of new front-end feedstock mechanical separators to improve feedstock purity and increase the range of feedstocks PCT can process economically. In addition, we are increasing our in-house feedstock analytical capabilities, which will include additional supporting equipment and personnel.

***Selling, General and Administrative Expense***

Selling, general and administrative expenses consist primarily of personnel-related expenses for our corporate, executive, finance and other administrative functions and professional services, including legal, audit and accounting services. We expect our selling, general, and administrative expenses to increase for the foreseeable future as we scale headcount with the growth of our business.

------

**PureCycle Technologies, Inc.**

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations — CONTINUED**

**Results of Operations**

***Comparison of Three and Nine Months ended September 30, 2025 and 2024***

The following table summarizes our operating results for the three and nine months ended September 30, 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| ***(in thousands)*** | **2025** | **2024** | **2025** | **2024** |
| Revenues | $2430 | $— | $5660 | $— |
| Operating expenses |  |  |  |  |
| &nbsp;&nbsp;Cost of operations | 29570 | 16965 | 82843 | 60379 |
| &nbsp;&nbsp;Research and development | 1443 | 1544) | 4381 | 4940) |
| &nbsp;&nbsp;Selling, general and administrative | 10350 | 12789) | 40688 | 44883) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 41363 | 31298 | 127912 | 110202 |
| Operating loss | (38933) | (31298) | (122252) | (110202) |
| Interest expense | 16235 | 14567 | 48939 | 41676 |
| Interest income | (2850) | (414) | (3850) | (4530) |
| Change in fair value of warrants | (23745) | 44899) | 1881 | 54532) |
| Loss on debt extinguishment |  |  |  | 21214) |
| Other (income)/expense | (203) | 289) | (5444) | 1364) |
| &nbsp;&nbsp;Total (income)/other expense | (10563) | 59341) | 41526 | 114256) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss | $(28370) | $(90639) | $(163778) | $(224458) |

---

***Revenues***

The Company reported approximately $2.4 million and $5.7 million in revenues during the three and nine months ended September 30, 2025, respectively. Fiscal year 2025 is the first year of meaningful operations. The Company is currently in various stages of customer application trials, which is anticipated to generate revenue growth in future periods.

***Cost of Operations***

Cost of operations increased approximately $12.6 million for the three months ended September 30, 2025 as compared to the three months ended September 30, 2024. Cost of operations for the three months ended September 30, 2025 included $4.9 million of higher professional services and contract labor driven by preliminary planning and design work for our Thailand and Augusta facilities, $3.2 million of higher production-related costs due to the ramp-up in production that has occurred during the current year as compared to the prior year, $2.6 million higher facilities costs attributable to the opening of our PreP facility in Denver, Pennsylvania in September of 2024, and the expansion of offsite storage and processing space, and $1.0 million of higher supplies and materials costs.

Cost of operations increased approximately $22.5 million for the nine months ended September 30, 2025 as compared to the nine months ended September 30, 2024. Cost of operations for the nine months ended September 30, 2025 included approximately $7.5 million higher production-related costs due to the ramp-up in production that occurred during the current year, $5.0 million of higher professional services and contract labor driven by preliminary planning and design work for our Thailand and Augusta facilities, $3.7 million in loss on disposal of fixed assets, $3.4 million higher employee-related expenses to support the expanded needs of the organization, $2.3 million of higher supplies and materials, and $1.3 million of higher facilities costs attributable to the opening of our PreP facility in Denver, Pennsylvania in September of 2024, and the expansion of offsite storage and processing space, partially offset by $1.7 million lower depreciation expense.

------

**PureCycle Technologies, Inc.**

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations — CONTINUED**

We intend to construct new polypropylene recycling facilities in Thailand and Belgium, and build a multi-line purification facility at our Augusta, Georgia location. Certain equipment that has been purchased for the Augusta Facility (and recorded as construction in progress) is currently being evaluated for use in the construction of the Thailand or Belgium facilities. If we determine that any of the Augusta equipment cannot be used in either Thailand, Belgium, in the redesigned Augusta facility, or re-purposed for other uses, we could incur a non-cash charge for the loss on disposition of such equipment. Currently, we are in the early stages of the planning and design of our Thailand, Belgium and Augusta facilities, so we are not yet able to determine the loss, if any, for equipment that may not be placed into operation.

***Research and Development Expenses***

Research and development expenses decreased approximately $0.1 million for the three months ended September 30, 2025 as compared to the three months ended September 30, 2024. This decrease was mainly driven by lower employee costs.

Research and development expenses decreased approximately $0.6 million for the nine months ended September 30, 2025 as compared to the nine months ended September 30, 2024. This decrease was primarily driven by $0.6 million of lower employee costs and $0.1 million of lower operational site costs, partially offset by $0.2 million of higher research and development activities.

***Selling, General and Administrative Expenses***

Selling, general and administrative expenses decreased approximately $2.4 million for the three months ended September 30, 2025 as compared to the three months ended September 30, 2024. This decrease was primarily driven by approximately $1.5 million of lower legal costs mostly as a result of settlement of outstanding cases in the prior year.

Selling, general and administrative expenses decreased approximately $4.2 million for the nine months ended September 30, 2025 as compared to the nine months ended September 30, 2024. This decrease was primarily driven by approximately $7.5 million of lower legal costs mostly as a result of settlement of outstanding cases in the prior year, partially offset by $3.5 million of higher equity-based compensation from new awards issued since the prior year, including a special grant valued at $2.3 million to the Chief Executive Officer that immediately vested upon grant, and $0.4 million higher employee-related expenses.

***Interest Expense***

Interest expense increased by $1.7 million for the three months ended September 30, 2025 as compared to the three months ended September 30, 2024. The increase in interest expense was primarily attributed to interest on the Company's Series A Preferred Stock issued during the third quarter of 2024 and higher interest on our Revenue Bonds as a result of current year sales of Revenue Bonds. The increase in interest expense was partially offset by a decrease in interest expense on equipment financing due to paydown of outstanding balances.

Interest expense increased by $7.3 million for the nine months ended September 30, 2025 as compared to the nine months ended September 30, 2024. The increase in interest expense was primarily attributed to interest on the Series A Preferred Stock issued during the third quarter of 2024 and higher interest on our Revenue Bonds as a result of current year sales of our Revenue Bonds. The increase in interest expense was partially offset by a decrease in interest expense on equipment financing and interest on the Pure Plastic Term Loan Facility paid off during the second quarter of 2024.

------

**PureCycle Technologies, Inc.**

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations — CONTINUED**

***Interest Income***

Interest income for the three months ended September 30, 2025 increased $2.4 million from three months ended September 30, 2024 due to higher cash balances as a result of the proceeds from the issuance of the Series B Convertible Perpetual Preferred Stock during the second quarter of 2025.

The interest income decrease of $0.7 million for the nine months ended September 30, 2025 as compared to the nine months ended September 30, 2024 was primarily attributable to the liquidation of our available-for-sale investment portfolio earlier during 2024, offset by the increase in the cash balance as a result of the proceeds from the issuance of the Series B Convertible Perpetual Preferred Stock during the second quarter of 2025.

***Change in Fair Value of Warrants***

During the three months ended September 30, 2025, the fair value of our liability-classified warrants decreased approximately $23.7 million, as compared to an increase in fair value of $44.9 million during the three months ended September 30, 2024. The decrease during the three months ended September 30, 2025 was primarily attributable to a decrease in the Company's Common Stock price during the quarter, combined with a decrease in the remaining term and implied volatility assumption as well as a decrease in the number of warrants during 2025 due to exercises during 2025. The increase during the three months ended September 30, 2024 was chiefly driven by an increase in the underlying price of the Company's Common Stock, combined with an increase in the number of warrants during 2024.

During the nine months ended September 30, 2025, the fair value of our liability-classified warrants increased by $1.9 million, as compared to an increase in the fair value of $54.5 million during the nine months ended September 30, 2024. The current year increase is mainly driven by an increase in the underlying value of our Common Stock, partially offset by fewer warrants outstanding as a result of current year warrant exercises combined with a decrease in the remaining term. The prior year increase was chiefly driven by an increase in the underlying price of the Company's Common Stock, combined with an increase in the number of warrants during 2024.

***Loss on Debt Extinguishment***

The Company recorded a loss associated with the repurchase of the Revenue Bonds in the first quarter of 2024. There have been no similar transactions during 2025.

***Other (Income)/Expense***

During the three months ended September 30, 2025, the $0.2 million of other income was primarily comprised of sublease income. During the three months ended September 30, 2024, the $0.3 million of other expense was primarily comprised of a $0.4 million increase in the fair value of the Series A Preferred Stock put option.

During the nine months ended September 30, 2025, the $5.4 million in other income was primarily comprised of a $3.4 million decrease in the fair value of the Series A Preferred Stock put option, resulting in a gain recorded in other income, and a net gain from insurance proceeds of approximately $1.3 million related to settlement of the shareholder derivative lawsuit. During the nine months ended September 30, 2024, the $1.4 million of other expense was primarily attributed to a $0.8 million impairment charge related to an operating right-of-use asset during the second quarter of 2024 plus a $0.4 million change in the fair value of the put option during the third quarter of 2024.

------

**PureCycle Technologies, Inc.**

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations — CONTINUED**

**Liquidity and Capital Resources**

Our ongoing operations have primarily been funded to date by a combination of equity financing through the issuance of Common Stock and preferred stock, as well as the issuance of various debt instruments. The Company's current financial projections support the Company's ability to meet its obligations as they become due for at least the twelve-month period from the date that these financial statements were issued. The Company's ability to meet its requirements longer term is dependent on continued improvement in operations at our Ironton Facility, the commercialization of our PureFive<sup>TM</sup> resin product, and the successful construction and sale of product from our Thailand facility. Management continues to evaluate different strategies and may pursue additional actions to further increase its liquidity position.

The following is a summary of the components of our current liquidity. As of September 30, 2025, restricted cash consisted primarily of certain amounts required to support outstanding letters of credit and other collateral, initial construction commitments for the Augusta Facility, and bond reserves for the Ironton Facility.

---

| | | |
|:---|:---|:---|
| ***(in thousands)*** | **September 30, 2025** | **December 31, 2024** |
| Cash and cash equivalents | $234359 | $15683 |
| Letters of credit and other collateral | 6397 | 6310 |
| Augusta Facility construction escrow | 3281 | 16398 |
| Ironton Facility bond reserves | 3216 | 3120 |
| &nbsp;&nbsp;&nbsp;Restricted cash (current and noncurrent) | 12894 | 25828 |
| Green Convertible Notes | 250000 | 250000 |
| Revenue Bonds | 148630 | 118630 |
| Equipment financing payable and other debt | 26162 | 31491 |
| Less: discount and issuance costs | (45705) | (53477) |
| &nbsp;&nbsp;&nbsp;Gross long-term debt and related party bonds payable | $379087 | $346644 |

---

As of September 30, 2025, we had approximately $234.4 million of cash and cash equivalents, which consists primarily of investments in money markets and commercial paper with original maturities of three months or less, as well as approximately $12.9 million of restricted cash. We also have a $200.0 million revolving credit facility ("Revolving Credit Facility") with Sylebra Capital Management ("Sylebra") that is undrawn and expires on September 30, 2027. On November 4, 2025, the Company entered into the Tenth Amendment to the Revolving Credit Agreement, which extended the maturity date of the Revolving Credit Facility from September 30, 2026 to September 30, 2027 and added a clause regarding the potential redemption of Series A Preferred Stock. If, on or prior to March 17, 2026, sufficient proceeds are received from the exercise of Series A Warrants and the Board of Directors approve, then the Company shall redeem in full the Series A Preferred Stock.

We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors. We do not have any off-balance sheet arrangements or interests in variable interest entities that would require consolidation. While certain legally binding offtake arrangements have been entered into with customers, these arrangements are not unconditional and definite agreements subject only to customer closing conditions, and do not qualify as off-balance sheet arrangements required for disclosure.

------

**PureCycle Technologies, Inc.**

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations — CONTINUED**

***Cash Flows***

A summary of our cash flows for the nine months ended September 30, 2025 and 2024 is as follows:

---

| | | |
|:---|:---|:---|
|  | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| ***(in thousands)*** | **2025** | **2024** |
| Net cash used in operating activities | $(114052) | $(112985) |
| Net cash (used in)/provided by investing activities | (27504) | 14586) |
| Net cash provided by/(used in) financing activities | 347298 | (110462) |
| &nbsp;&nbsp;&nbsp;Net increase/(decrease) in cash and cash equivalents and restricted cash | 205742 | (208861) |
| Cash and cash equivalents and restricted cash, beginning of period | 41511 | 302514) |
| **Cash and cash equivalents and restricted cash, end of period** | $**247253** | $**93653** |

---

***Cash Flows from Operating Activities***

Net cash used in operating activities for the nine months ended September 30, 2025 increased by $1.1 million as compared to the nine months ended September 30, 2024. This increase is mainly attributed to higher operating costs in connection with the ramp-up in production at the Ironton Facility during 2025.

***Cash Flows from Investing Activities***

During the nine months ended September 30, 2025, we reported cash used in investing activities of approximately $27.5 million, which was entirely comprised of cash paid for capital expenditures during that period. During the nine months ended September 30, 2024, we reported cash provided by investing activities of approximately $14.6 million, which is comprised of approximately $79.2 million of cash proceeds from the sale of debt securities, partially offset by capital expenditures of $34.0 million, and the purchase of debt securities totaling $30.6 million. We sold all of our debt securities during 2024 and had no similar type transactions during 2025.

***Cash Flows from Financing Activities***

We reported net cash provided by financing activities of approximately $347.3 million during the nine months ended September 30, 2025 as compared to net cash used in financing activities of approximately $110.5 million during the nine months ended September 30, 2024.

Cash provided by financing activities for the nine months ended September 30, 2025 is primarily comprised of $300.0 million of proceeds from the issuance of the Series B Convertible Perpetual Preferred Stock during the second quarter of 2025, $33.5 million of proceeds from the issuance of the Company's Common Stock, $26.9 million of proceeds from the sale of Revenue Bonds, $14.9 million in proceeds on draws on our Revolving Credit Facility and a short-term borrowing from a related party, $6.6 million in proceeds from the exercise of the RTI Global Warrants, Series A Warrants and private warrants during 2025, and $0.7 million in proceeds for other financing activities. These cash inflows were partially offset by $14.9 million in payments on our Revolving Credit Facility and a short-term borrowing from a related party, $7.7 million in payments on equipment financing, $7.6 million in debt and preferred stock issuance costs paid, and $4.5 million in payments to repurchase shares.

Cash used in financing activities for the nine months ended September 30, 2024 is mainly comprised of $253.2 million paid to purchase the outstanding Revenue Bonds during 2024, $3.1 million in payments on equipment financing, $1.1 million in payments to repurchase shares of the Company's Common Stock, and $1.1 million in debt issuance costs paid. These outflows are partially offset by $48.0 million of proceeds from the sale of Revenue

------

**PureCycle Technologies, Inc.**

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations — CONTINUED**

Bonds, $38.1 million of proceeds from the issuance of the Company's Common Stock, $30.1 million of proceeds from the issuance of warrants, $21.8 million in proceeds from the issuance of our Series A Preferred Stock, $9.5 million of proceeds from equipment lease financing, and $0.6 million of other net proceeds from financing activities.

***Indebtedness***

There have been no material changes regarding our indebtedness from the information we provided in our most recent Annual Report on Form 10-K, *except* as outlined in the information below. Refer to Note 8 *- Long-Term Debt and Bonds Payable* to our unaudited condensed consolidated financial statements included in Part I, Item 1. "Financial Statements."

***Revenue Bonds***

The Company sold $30.5 million par value in Revenue Bonds during the nine months ended September 30, 2025. See Note 8 *- Long-Term Debt and Bonds Payable* to our unaudited condensed consolidated financial statements included in Part I, Item 1. "Financial Statements."

***Revenue Bonds Issued to Related Party***

See Note 8 *- Long-Term Debt and Bonds Payable* to our unaudited condensed consolidated financial statements included in Part I, Item 1. "Financial Statements."

***Revolving Credit Facility with Sylebra***

See Note 8 *- Long-Term Debt and Bonds Payable* to our unaudited condensed consolidated financial statements included in Part I, Item 1. "Financial Statements."

***Financial Assurance***

See Note 8 *- Long-Term Debt and Bonds Payable* to our unaudited condensed consolidated financial statements included in Part I, Item 1. "Financial Statements."

**Critical Accounting Policies and Estimates**

There have been no significant changes in our critical accounting policies and estimates from the information we provided in our most recent Annual Report on Form 10-K.

**Recent Accounting Pronouncements**

See Note 2 - *Summary of Significant Accounting Policies* to the unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for more information about recent accounting pronouncements, the timing of their adoption, and our assessment, to the extent we have made one, of their potential impact on our financial condition and our results of operations.

------

**PureCycle Technologies, Inc.**

**Item 3. Quantitative and Qualitative Disclosures About Market Risk**

Information about market risks as of September 30, 2025 does not differ materially from that included in our most recent Annual Report on Form 10-K.

**Item 4. Controls and Procedures**

**Evaluation of Disclosure Controls and Procedures**

Our management, with the participation of our principal executive and financial officers, has evaluated the effectiveness of our disclosure controls and procedures in ensuring that the information required to be disclosed in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, including ensuring that such information is accumulated and communicated to management (including the principal executive and financial officers) as appropriate to allow timely decisions regarding required disclosure. Based on such evaluation, our principal executive and financial officers have concluded that such disclosure controls and procedures were effective as of September 30, 2025 (the end of the period covered by this Quarterly Report on Form 10-Q).

**Changes in Internal Control over Financial Reporting**

There have been no changes during the period covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

------

**PureCycle Technologies, Inc.**

**PART II — OTHER INFORMATION**

**Item 1. Legal Proceedings**

For a description of the legal proceedings pending against us, see "Legal Proceedings" in *Note 10* - Commitments and Contingencies - to the Notes to the condensed consolidated financial statements appearing elsewhere in this Quarterly Report on Form 10-Q.

In the future, we may become party to additional legal matters and claims arising in the ordinary course of business. While we are unable to predict the outcome of the above or future matters, we do not believe, based upon currently available facts, that the ultimate resolution of any such pending matters will have a material adverse effect on our overall financial position, results of operations, or cash flows.

**Item 1A. Risk Factors**

There have been no material changes from risk factors previously disclosed in our most recent Annual Report on Form 10-K in response to Part 1, Item 1A.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds**

**Purchases of Equity Securities by the Issuer and Affiliated Purchasers**

The following table provides information with respect to the Company's purchases of its Common Stock for the third quarter of 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Period** | **(a) Total number of shares (or units) purchased\*** | **(b) Average price paid per share (or unit)\*** | **(c) Total number<br>of shares (or units) purchased<br>as part of<br>publicly<br>announced plans or programs** | **(d) Maximum<br>number (or<br>approximate<br>dollar value) of<br>shares (or units)<br>that may yet be<br>purchased under<br>the plans or programs** |
| July 1 to July 31 | 72527 | $9.88 |  | $— |
| August 1 to August 31 | 16912 | 13.11 |  |  |
| September 1 to September 30 | 36278 | 13.90 |  |  |
| &nbsp;&nbsp;Total | 125717 | $11.47 |  | $— |

---

\* Shares withheld to cover tax withholding obligations under the net settlement provision upon vesting of restricted stock units.

------

**PureCycle Technologies, Inc.**

**PART II — OTHER INFORMATION — CONTINUED**

**ITEM 5. Other Information**

**Rule 10b5-1 Trading Plans**

None of our directors or officers adopted, modified, or terminated a "Rule 10b5-1 trading arrangement" or a "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408 of Regulation S-K, during the fiscal quarter ended September 30, 2025.

------

**PureCycle Technologies, Inc.**

**PART II — OTHER INFORMATION — CONTINUED**

**ITEM 6. Exhibits**

---

| | |
|:---|:---|
| **Exhibit**<br>**Number** | **Description of Exhibit** |
| 2.1 | [<u>Agreement and Plan of Merger, dated as of November 16, 2020, by and among Roth CH Acquisition I Co., Roth CH Acquisition I Co. Parent Corp., Roth CH Merger Sub, LLC, Roth CH Merger Sub, Inc. and PureCycle Technologies LLC. (incorporated herein by reference to Exhibit 2.1 to the Company's Registration Statement on Form S-4, as amended (File No. 333-250847)) †</u>](https://www.sec.gov/Archives/edgar/data/1830033/000110465920128027/tm2034179-1_s4.htm#tANNEXA) |
| 3.1 | [<u>Amended and Restated Certificate of Incorporation of PureCycle Technologies, Inc., filed with the Secretary of State of Delaware on March 17, 2021 (incorporated herein by reference to Exhibit 3.1 to the Company's Registration Statement on Form S-1, as amended (File No. 333-251034))</u>](https://www.sec.gov/Archives/edgar/data/0001830033/000110465921038796/tm219744d4_ex3-1.htm) |
| 3.2 | [<u>Certificate of Amendment to the Amended and Restated Certificate of Incorporation of PureCycle Technologies, Inc. to Declassify the Board of Directors (incorporated herein by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed on May 15, 2023)</u>](https://www.sec.gov/Archives/edgar/data/1830033/000183003323000039/pct5152023ex31xcertificate.htm) |
| 3.3 | [<u>Certificate of Amendment to the Amended and Restated Certificate of Incorporation of PureCycle Technologies, Inc. to Incorporate Certain Other Changes (incorporated herein by reference to Exhibit 3.2 to the Company's Current Report on Form 8-K filed on May 15, 2023)</u>](https://www.sec.gov/Archives/edgar/data/1830033/000183003323000039/pct5152023ex32xcertificate.htm) |
| 3.4 | [<u>Certificate of Designations of Series A Preferred Stock of PureCycle Technologies, Inc. (incorporated herein by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed on September 13, 2024)</u>](https://www.sec.gov/Archives/edgar/data/1830033/000095017024106348/pct-ex3_1.htm) |
| 3.5 | [<u>Second Amended and Restated Bylaws of PureCycle Technologies, Inc. (incorporated herein by reference to Exhibit 3.3 to the Company's Current Report on Form 8-K filed on May 15, 2023)</u>](https://www.sec.gov/Archives/edgar/data/1830033/000183003323000039/pct5152023ex33xexbxamended.htm) |
| 3.6 | [<u>Certificate of Designations of Series B Convertible Perpetual Stock of PureCycle Technologies, Inc. (incorporated herein by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed June 23, 2025)</u>](https://www.sec.gov/Archives/edgar/data/1830033/000110465925061724/tm2518118d2_ex3-1.htm) |
| 31.1 | [<u>Rule 13a – 14(a) Certification by Dustin Olson, Chief Executive Officer, for the quarter ended September 30, 2025\*</u>](pct-ex31_1.htm) |
| 31.2 | [<u>Rule 13a – 14(a) Certification by Jaime Vasquez, Chief Financial Officer, for the quarter ended September 30, 2025\*</u>](pct-ex31_2.htm) |
| 32.1 | [<u>Section 1350 Certification by Dustin Olson, Chief Executive Officer, for the quarter ended September 30, 2025^</u>](pct-ex32_1.htm) |
| 32.2 | [<u>Section 1350 Certification by Jaime Vasquez, Chief Financial Officer, for the quarter ended September 30, 2025^</u>](pct-ex32_2.htm) |
| 101.1 | The following financial statements from PureCycle Technologies, Inc.'s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025, formatted in Inline XBRL (eXtensible Business Reporting Language): |
|  | (i) Consolidated Balance Sheets as of September 30, 2025 (Condensed and Unaudited) and December 31, 2024. |
|  | (ii) Unaudited Condensed Consolidated Statements of Comprehensive Loss for the Three and Nine Months Ended September 30, 2025 and 2024. |
|  | (iii) Unaudited Condensed Consolidated Statements of Mezzanine Equity and Stockholders' Equity for the Three and Nine Months Ended September 30, 2025 and 2024. |
|  | (iv) Unaudited Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2025 and 2024. |
|  | (v) Notes to the Condensed Consolidated Financial Statements. |

---

------

**PureCycle Technologies, Inc.**

**PART II — OTHER INFORMATION — CONTINUED**

104.1 Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101.1)

\* Filed electronically herewith.

^ Furnished electronically herewith.

\*\* Certain identified information has been excluded from this exhibit pursuant to Rule 601(b)(10) of Regulation S-K because it is both (i) not material and (ii) is the type of information that the registrant treats as private or confidential.

† Schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The registrant hereby undertakes to furnish copies of any of the omitted schedules upon request by the Securities and Exchange Commission.

------

**PureCycle Technologies, Inc.**

**PART II — OTHER INFORMATION — CONTINUED**

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
| **PURECYCLE TECHNOLOGIES, INC.** | **PURECYCLE TECHNOLOGIES, INC.** |
| (Registrant) | (Registrant) |
| By:  | /s/ Dustin Olson |
| Dustin Olson | Dustin Olson |
| Chief Executive Officer | Chief Executive Officer |
| (Principal Executive Officer) | (Principal Executive Officer) |

---

---

| | |
|:---|:---|
| By:  | /s/ Jaime Vasquez |
| Jaime Vasquez | Jaime Vasquez |
| Chief Financial Officer | Chief Financial Officer |
| (Principal Financial Officer) | (Principal Financial Officer) |
| Date: November 6, 2025 | Date: November 6, 2025 |

---

------

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER**

I, Dustin Olson, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this Quarterly Report on Form 10-Q of PureCycle Technologies, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in the Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date:  | November 6, 2025 |
| By:  | <u>/s/ Dustin Olson</u>  |
| Dustin Olson | Dustin Olson |
| Chief Executive Officer | Chief Executive Officer |
| *(Principal Executive Officer)* | *(Principal Executive Officer)* |

---

------

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATION OF CHIEF FINANCIAL OFFICER**

I, Jaime Vasquez, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this Quarterly Report on Form 10-Q of PureCycle Technologies, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in the Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date:  | November 6, 2025 |
| By:  | <u>/s/ Jaime Vasquez</u> |
| Jaime Vasquez | Jaime Vasquez |
| Chief Financial Officer | Chief Financial Officer |
| *(Principal Financial Officer)* | *(Principal Financial Officer)* |

---

------

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER**

**PURSUANT TO 18 U.S.C. SECTION 1350**

**AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of PureCycle Technologies, Inc. (the "Company") on Form 10-Q for the period ended September 30, 2025 (the "Report"), Dustin Olson, Chief Executive Officer of the Company, certifies, to the best of his knowledge, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 6, 2025

---

| | |
|:---|:---|
| By: | &nbsp;&nbsp;/s/ Dustin Olson |
| Dustin Olson | Dustin Olson |
| Chief Executive Officer<br>*(Principal Executive Officer)* | Chief Executive Officer<br>*(Principal Executive Officer)* |

---

------

## Exhibit 32.2

**Exhibit 32.2**

**CERTIFICATION OF CHIEF FINANCIAL OFFICER**

**PURSUANT TO 18 U.S.C. SECTION 1350**

**AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of PureCycle Technologies, Inc. (the "Company") on Form 10-Q for the period ended September 30, 2025 (the "Report"), Jaime Vasquez, Chief Financial Officer of the Company, certifies, to the best of his knowledge, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 6, 2025

---

| | |
|:---|:---|
| By: | /s/ Jaime Vasquez |
| Jaime Vasquez | Jaime Vasquez |
| Chief Financial Officer  | Chief Financial Officer  |
| *(Principal Financial Officer)* | *(Principal Financial Officer)* |

---

------